[Date Prev] | [Thread Prev] | [Thread Next] | [Date Next] -- [Date Index] | [Thread Index] | [List Home]
Subject: CurrentId and Example
On behalf of Veronique. Thanks to Veronique! Monica
<?xml version="1.0" encoding="UTF-8"?>
<akomaNtoso xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0/CSD08";
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance";
xsi:schemaLocation="http://docs.oasis-open.org/legaldocml/ns/akn/3.0/CSD08 file:/C:/xml4ep/schemas/akomantoso30.xsd">
<documentCollection name="COMproposal" contains="singleVersion">
<meta>
<identification source="#parisse">
<FRBRWork>
<FRBRthis currentId="FRBRWork__FRBRthis" value="/eu/documentCollection/COMproposal/COM/2013-09-17/619/main"/>
<FRBRuri currentId="FRBRWork__FRBRuri" value="/eu/documentCollection/COMproposal/COM/2013-09-17/619"/>
<FRBRalias currentId="FRBRWork__FRBRalias_1" name="xml4ep:/doc/idSchema/COMnumber" value="COM(2013)0619"/>
<FRBRalias currentId="FRBRWork__FRBRalias_2" name="xml4ep:/doc/idSchema/CELEXnumber" value="52013PC0619"/>
<FRBRdate currentId="FRBRWork__FRBRdate_1" date="2013-09-17" name="instantiation"/>
<FRBRauthor currentId="FRBRWork__FRBRauthor_1" href="eu.europa.europarl.codict:institution/id=10" as="xml4ep:/role/procedure/initiativeRight"/>
<componentInfo>
<componentData currentId="FRBRWork.componentData.explanation" name="Explanation" href="#component_1" showAs="Explanatory memorandum"/>
<componentData currentId="FRBRWork.componentData.bill" name="bill" href="#component_2" showAs="Proposal for a regulation of the European Parliament and of the Council"/>
<componentData currentId="FRBRWork.componentData.financialStatement" name="financialStatement" href="#component_3" showAs="Financial statement"/>
</componentInfo>
<FRBRcountry currentId="FRBRWork__FRBRcountry" value="eu"/>
<FRBRprescriptive currentId="FRBRWork__FRBRprescriptive" value="false"/>
<FRBRauthoritative currentId="FRBRWork__FRBRauthoritative" value="false"/>
</FRBRWork>
<FRBRExpression>
<FRBRthis currentId="FRBRExpression__FRBRthis" value="/eu/documentCollection/COMproposal/COM/2013-09-17/619/main/en@final"/>
<FRBRuri currentId="FRBRExpression__FRBRuri" value="/eu/documentCollection/COMproposal/COM/2013-09-17/619/main/en@final"/>
<FRBRdate currentId="FRBRExpression__FRBRdate_1" date="2013-09-17" name="instantiation"/>
<FRBRauthor currentId="FRBRExpression__FRBRauthor_1" href=""/>
<componentInfo>
<componentData currentId="FRBRExpression.componentData.explanation" name="Explanation" href="#component_1" showAs="Explanatory memorandum"/>
<componentData currentId="FRBRExpression.componentData.bill" name="bill" href="#component_2" showAs="Proposal for a regulation of the European Parliament and of the Council"/>
<componentData currentId="FRBRExpression.componentData.financialStatement" name="financial" href="#component_3" showAs="Financial statement"/>
</componentInfo>
<FRBRlanguage currentId="FRBRExpression__FRBRlanguage_1" language="en"/>
</FRBRExpression>
<FRBRManifestation>
<FRBRthis currentId="FRBRManifestation__FRBRthis" value="/eu/documentCollection/COMproposal/COM/2013-09-17/619/main/en@final#.xml"/>
<FRBRuri currentId="FRBRManifestation__FRBRuri" value="/eu/documentCollection/COMproposal/COM/2013-09-17/619/main/en@final#.akn"/>
<FRBRdate currentId="FRBRManifestation__FRBRdate_1" date="2013-09-17" name="instantiation"/>
<FRBRauthor currentId="FRBRManifestation__FRBRauthor_1" href="#parisse" as="#poc"/>
<componentInfo>
<componentData currentId="FRBRManifestation.componentData" name="img" href="eu/europeanCommission/img/commission/logo/@logo-png" showAs="European Commission logo"/>
</componentInfo>
</FRBRManifestation>
</identification>
<classification source="#eurlex">
<keyword currentId="ontology.eurovoc.echangeInformation" value="échange d'information" showAs="échange d'information" dictionary="EUROVOC"/>
<keyword currentId="ontology.eurovoc.autorisationDeVente" value="autorisation de vente" showAs="autorisation de vente" dictionary="EUROVOC"/>
<keyword currentId="ontology.eurovoc.risqueSanitaire" value="risque sanitaire" showAs="risque sanitaire" dictionary="EUROVOC"/>
<keyword currentId="ontology.eurovoc.traficDeStupefiants" value="trafic de stupéfiants" showAs="trafic de stupéfiants" dictionary="EUROVOC"/>
<keyword currentId="ontology.eurovoc.substancePsychotrope" value="substance psychotrope" showAs="substance psychotrope" dictionary="EUROVOC"/>
<keyword currentId="ontology.eurovoc.conventionONU" value="convention ONU" showAs="convention ONU" dictionary="EUROVOC"/>
</classification>
<lifecycle source="#parisse">
<eventRef currentId="lifecycle_1__eventRef_1" date="2013-09-17" source="#orig" type="generation"/>
</lifecycle>
<references source="#parisse">
<original currentId="references_1__original_1" href="" showAs="Original"/>
<TLCOrganization currentId="eu.europa.europarl.codict_institution-10" href="eu.europa.europarl.codict:institution/id=10" showAs="EUROPEAN COMMISSION"/>
<TLCOrganization currentId="eu.europa.europarl.codict_institution-11" href="eu.europa.europarl.codict:institution/id=10" showAs="COUNCIL"/>
<TLCOrganization currentId="eu.europa.europarl.codict_institution-27" href="eu.europa.europarl.codict:institution/id=10" showAs="EUROPEAN PARLIAMENT"/>
<TLCProcess currentId="eurLex" href="www.eurlex.com" showAs="EurLex"/>
<TLCPerson currentId="parisse" href="/ontology/person/vparisse" showAs="V. Parisse"/>
<TLCRole currentId="poc" href="/ontology/roles/proofOfConcept" showAs="Proof of concept"/>
</references>
<proprietary currentId="proprietary_1" source="#parisse">
<!-- indicate the element that are, in the context of this xml file, globally numbered -->
<ep:noIntraPrefix xmlns:ep="www.europarl.eu.int" currentId="proprietary_1__ep:noIntraPrefix_1" element="tblock;authorialNote"/>
</proprietary>
</meta>
<coverPage currentId="coverPage">
<container currentId="coverPage__container_1" name="titlePage">
<p currentId="coverPage__container_1__p_1"><img currentId="coverPage__container_1__p_1__img_1" src="eu/europeanCommission/img/commission/logo/@logo-png"/></p>
<p currentId="coverPage__container_1__p_2"><organization currentId="coverPage__container_1__p_2__organization_1" refersTo="#eu.europa.europarl.codict_institution-10">EUROPEAN
COMMISSION</organization></p>
<p currentId="coverPage__container_1__p_3"><legislature currentId="coverPage__container_1__p_3__legislature_1">2009-2014</legislature></p>
</container>
<container currentId="coverPage__container_2" name="repeatable">
<block currentId="coverPage__container_2__block_1" name="coverFooter">
<inline currentId="coverPage__container_2__block_1__inline_1" name="language" refersTo="#FRBRExpression__FRBRlanguage_1">EN</inline>
</block>
</container>
</coverPage>
<preface currentId="preface">
<container currentId="preface__container_1" name="mainDoc">
<p currentId="preface__container_1__p_1">Brussels, <docDate currentId="preface__container_1__p_1__docDate_1" date="2013-09-17">17.9.2013</docDate></p>
<p currentId="preface__container_1__p_2"><docNumber currentId="preface__container_1__p_2__docNumber_1">COM(2013) 619 final</docNumber></p>
<p currentId="preface__container_1__p_3"><docketNumber currentId="preface__container_1__p_3__docketNumber_1">2013/0305 (COD)</docketNumber></p>
</container>
<longTitle currentId="preface__ltti_1">
<p><docStage currentId="preface__ltti_1__p_1__docStage_1">Proposal for a</docStage>
<docType currentId="preface__ltti_1__p_1__docType_1">REGULATION</docType><docAuthority currentId="preface__ltti_1__p_1__docAuthority_1"> OF THE EUROPEAN PARLIAMENT AND OF
THE COUNCIL</docAuthority>
<docPurpose currentId="preface__ltti_1__p_1__docPurpose_1">on new psychoactive substances</docPurpose></p>
</longTitle>
<container currentId="preface__container_2" name="relevance">
<p>(Text with EEA relevance)</p>
</container>
<container currentId="preface__container_3" name="docs">
<p currentId="preface__container_3__p_1">{SWD(2013) 319 final} </p>
<p currentId="preface__container_3__p_2">{SWD(2013) 320 final}</p>
</container>
</preface>
<collectionBody>
<component currentId="collectionBody__component_1">
<documentRef currentId="collectionBody__component_1__documentRef" href="#component_1" showAs="Explanatory memorandum"/>
</component>
<component currentId="collectionBody__component_2">
<documentRef currentId="collectionBody__component_2__documentRef" href="#component_2" showAs="Proposal"/>
</component>
<component currentId="collectionBody__component_3">
<documentRef currentId="collectionBody__component_3__documentRef" href="#component_3" showAs="Financial statement"/>
</component>
</collectionBody>
</documentCollection>
<components>
<component currentId="component_1">
<doc name="explanation" contains="originalVersion">
<meta>
<identification source="http://www.europarl.europa.eu/";>
<FRBRWork>
<FRBRthis currentId="doc_1__component_1__FRBRWork__FRBRthis" value=""/>
<FRBRuri currentId="doc_1__component_1__FRBRWork__FRBRuri" value=""/>
<FRBRdate currentId="doc_1__component_1__FRBRWork__FRBRdate_1" date="2012-01-01" name="instantiation"/>
<FRBRauthor currentId="doc_1__component_1__FRBRWork__FRBRauthor_1" href="eu.europa.europarl.codict:institution/id=10" as="xml4ep:/role/document/author"/>
<FRBRcountry currentId="doc_1__component_1__FRBRWork__FRBRcountry" value="eu"/>
<FRBRprescriptive currentId="doc_1__component_1__FRBRWork__FRBRprescriptive" value="false"/>
<FRBRauthoritative currentId="doc_1__component_1__FRBRWork__FRBRauthoritative" value="false"/>
</FRBRWork>
<FRBRExpression>
<FRBRthis currentId="doc_1__component_1__FRBRExpression__FRBRthis" value=""/>
<FRBRuri currentId="doc_1__component_1__FRBRExpression__FRBRuri" value=""/>
<FRBRdate currentId="doc_1__component_1__FRBRExpression__FRBRdate_1" date="2012-01-01" name="instantiation"/>
<FRBRauthor currentId="doc_1__component_1__FRBRExpression__FRBRauthor_1" href="eu.europa.europarl.codict:institution/id=10"/>
<FRBRlanguage currentId="doc_1__component_1__FRBRExpression__FRBRlanguage_1" language="en"/>
</FRBRExpression>
<FRBRManifestation>
<FRBRthis currentId="doc_1__component_1__FRBRManifestation__FRBRthis" value=""/>
<FRBRuri currentId="doc_1__component_1__FRBRManifestation__FRBRuri" value=""/>
<FRBRdate currentId="doc_1__component_1__FRBRManifestation__FRBRdate_1" date="2012-01-01" name="instantiation"/>
<FRBRauthor currentId="doc_1__component_1__FRBRManifestation__FRBRauthor_1" href=""/>
</FRBRManifestation>
</identification>
</meta>
<preface currentId="doc_1__preface">
<longTitle currentId="doc_1__preface__ltti_1">
<p>EXPLANATORY MEMORANDUM</p>
</longTitle>
</preface>
<mainBody currentId="doc_1__component_1__mainBody">
<tblock currentId="doc_1__tblock_1">
<num>1.</num>
<heading currentId="doc_1__tblock_1__heading">CONTEXT OF THE PROPOSAL</heading>
<tblock currentId="doc_1__tblock_1.1">
<num>1.1.</num>
<heading currentId="doc_1__tblock_1.1__heading">General context</heading>
<p currentId="doc_1__tblock_1.1__p_1">A growing number of new psychoactive substances, which imitate the
effects of substances controlled under the UN Conventions on Drugs
and are marketed as legal alternatives to them (â??legal highsâ??), are
emerging and spreading fast in the internal market. These
substances, which act on the central nervous system, modifying
mental functions, also have uses in industry or research - as active
substances for medicines, for instance. A rising number of
individuals, in particular young people, consume new psychoactive
substances, despite the risks that they may pose, which may be
comparable to those posed by UN-controlled drugs.</p>
<p currentId="doc_1__tblock_1.1__p_2">During the past years, one new psychoactive substance was reported
every week in the EU, and the rapid pace of notification is expected
to continue in the coming years. These substances are sold freely,
unless public authorities subject them to various restriction
measures, underpinned by administrative or criminal sanctions,
because of the risks that they pose when consumed by humans. Such
national restriction measures, which may differ depending on the
Member State and on the substance, can hamper trade in the internal
market and hinder the development of future industrial or commercial
uses.</p>
<p currentId="doc_1__tblock_1.1__p_3"><u currentId="doc_1__tblock_1.1__p_3__u_1">New</u> psychoactive substances are not subjected to control
measures under the UN Conventions on Drugs, unlike psychoactive
substances such as cocaine or amphetamines, although they could be
considered for UN-level control on the basis of a risk assessment
conducted by the World Health Organisation at the request of at
least one UN Member State.</p>
<p currentId="doc_1__tblock_1.1__p_4">The Commission Communication "Towards a stronger European response to
drugs"<authorialNote currentId="doc_1__authorialNote_1" marker="1" placement="bottom">
<p>COM(2011) 689 final.</p>
</authorialNote>, adopted in October 2011, identified the spread of
new psychoactive substances as one of the most challenging
developments in drugs policy requiring a firmer EU response. The
Communication set the ground for new EU legislative proposals on new
psychoactive substances, building on the Council Decision
2005/387/JHA on the information exchange, risk assessment and
control of new psychoactive substances<authorialNote currentId="doc_1__authorialNote_2" marker="2" placement="bottom">
<p>OJ L 127, 10.5.2005, p.32.</p>
</authorialNote>. In December 2011<authorialNote currentId="doc_1__authorialNote_3" marker="3" placement="bottom">
<p><a currentId="doc_1__authorialNote_3__p_1__a_1" href="http://www.consilium.europa.eu/uedocs/cms_data/docs/pressdata/en/jha/126879.pdf";>http://www.consilium.europa.eu/uedocs/cms_data/docs/pressdata/en/jha/126879.pdf</a></p>
</authorialNote>, the Council requested the Commission to table a
legislative proposal revising Council Decision 2005/387/JHA. A
legislative proposal on new psychoactive substances is foreseen in
the Commission's 2013 Work Programme<authorialNote currentId="doc_1__authorialNote_4" marker="4" placement="bottom">
<p>COM(2012) 629 final.</p>
</authorialNote>.</p>
<p currentId="doc_1__tblock_1.1__p_5">This proposal for a Regulation aims at improving the functioning of
the internal market regarding licit uses of new psychoactive
substances, by reducing obstacles to trade, preventing the emergence
of such obstacles and increasing legal certainty for economic
operators, while reducing the availability of substances that pose
risks through swifter, more effective and more proportionate EU
action. It is accompanied by a proposal for a Directive amending
Council Framework Decision 2004/757/JHA of 25 October 2004 laying
down minimum provisions on the constituent elements of criminal acts
and penalties in the field of illicit drug trafficking<authorialNote currentId="doc_1__authorialNote_5" marker="5" placement="bottom">
<p>OJ L 335, 11.11.2004, p. 8.</p>
</authorialNote>. This aims at expanding the scope of application of
the Framework Decision to cover the most harmful new psychoactive
substances, which pose <u currentId="doc_1__tblock_1.1__p_5__u_1">severe</u> risks. This means that
substances that pose severe health, social and safety risks and are,
therefore, submitted to permanent market restriction under this
proposed Regulation, are also covered, through the proposed amended
Framework Decision, by the criminal law provisions applying to
controlled drugs.</p>
<p currentId="doc_1__tblock_1.1__p_6">The case for swifter, more effective and more proportionate action on
new psychoactive substances at EU level is compelling, considering
the rapid changes in this market, which put national authorities
under pressure to act. During the past years, Member States have
notified an increasing number of new psychoactive substances to the
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
Between 1997 and 2012 they reported around 290 substances. The
number of notified substances tripled between 2009 and 2012 (from 24
to 73). Around 80% of these substances were reported by more than
one Member State. The number of substances that can emerge may run
into the thousands because many variations of existing or new, still
unexploited substances, can be manufactured at relatively low cost.
The issue has been further highlighted in the 2012<authorialNote currentId="doc_1__authorialNote_6" marker="6" placement="bottom">
<p>EMCDDA, 2012 <i currentId="doc_1__authorialNote_6__p_1__i_1">Annual report on the state of the drugs
problem in Europe</i>; available at:
http://www.emcdda.europa.eu/publications/annual-report/2012</p>
</authorialNote>and 2013<authorialNote currentId="doc_1__authorialNote_7" marker="7" placement="bottom">
<p>EMCDDA, <i currentId="doc_1__authorialNote_7__p_1__i_1">European Drug Report 2013</i>; available at:
http://www.emcdda.europa.eu/edr2013.</p>
</authorialNote>EMCDDA annual reports, as well as in the
EMCCDA-Europol "EU drug markets report: a strategic
analysis"<authorialNote currentId="doc_1__authorialNote_8" marker="8" placement="bottom">
<p>Available at:
http://www.emcdda.europa.eu/publications/joint-publications/drug-markets</p>
</authorialNote>, published in January 2013.</p>
<p currentId="doc_1__tblock_1.1__p_7">Consumption of new psychoactive substances appears to be increasing
in Europe and use is predominant among young people. According to
the 2011 Eurobarometer â??Youth attitudes on drugsâ??, 5% of young
people in the EU have used such substances at least once in their
life, with a peak of 16% in Ireland, and close to 10% in Poland,
Latvia and the UK. According to the results of snapshot surveys
conducted by the EMCDDA, the number of online shops selling new
psychoactive substances increased four-fold between 2010 and 2012,
to 690.</p>
<p currentId="doc_1__tblock_1.1__p_8">The consumption of new psychoactive substances can cause harms to
individuals' health and safety, resulting in deaths, injury or
disease, and can pose risks to and burdens on society, as it may
lead to violent behaviour and crime. These risks are amplified by
the fact that many such substances are sold to consumers without
appropriate labelling and instructions of use. In some cases they
are sold on the black market alongside, or instead of, controlled
drugs.</p>
<p currentId="doc_1__tblock_1.1__p_9">The rapid emergence and spread of these substances, and the potential
risks that they pose, have led national authorities to subject them
to various restriction measures. Hundreds such substances or
mixtures of substances have been subjected to different restriction
measures in the Member States in the past years. Such national
measures disrupt trade in licit uses of these substances. Around a
fifth of the substances notified by the Member States have other
uses (but information on such uses is not collected systematically
across the EU).</p>
<p currentId="doc_1__tblock_1.1__p_10">National restriction measures, which can vary depending on the Member
State and on the substance, lead to obstacles to trade in licit
uses, fragmentation, an uneven level playing field and legal
uncertainties for economic operators, and make it difficult for
companies to operate across the internal market. They make research
more cumbersome, hampering the development of new uses for these
substances. They have a chain-reaction impact on operators in
different markets, because such substances are used in the
production of other substances or mixtures, which in turn are used
for manufacturing various goods. As the market for new psychoactive
substances is likely to grow, so will these obstacles to licit
trade.</p>
<p currentId="doc_1__tblock_1.1__p_11">In order to facilitate the functioning of the internal market while
protecting consumers from harmful new psychoactive substances,
EU-level action shall ensure the free movement of new psychoactive
substances for commercial and industrial use, and for scientific
research and development, and provide for a graduated set of
restriction measures for substances posing risks, proportionate to
their level of risk.</p>
<p currentId="doc_1__tblock_1.1__p_12">This proposal, therefore, sets up a robust system for exchanging
rapidly information on new psychoactive substances emerging on the
market, including on their commercial and industrial uses, for
assessing the risks of substances that cause EU-wide concern and for
withdrawing from the market those substances that pose risks.</p>
<p currentId="doc_1__tblock_1.1__p_13">The substances suspected to pose immediate public health risk will be
withdrawn from the consumer market temporarily, pending their risk
assessment. Once the risk assessment is completed, measures will be
taken proportionate to the risks of substances. While no
restrictions will be introduced at the EU level on substances posing
low health, social and safety risks, substances posing moderate
risks will be subjected to consumer market restriction, which means
that they cannot be sold to consumers (except for uses specifically
authorised, for instance by medicines legislation) but their trade
is allowed for commercial and industrial purposes as well as for
scientific research and development.</p>
<p currentId="doc_1__tblock_1.1__p_14">New psychoactive substances posing severe risks will be subjected to
permanent market restriction, covering both the consumer and
commercial markets, and their use will only be possible for
specifically authorised industrial and commercial purposes, as well
as for scientific research and development. In addition, as
explained above, these substances will be subjected to EU criminal
law provisions under the accompanying proposal for a Directive
amending the Framework Decision on illicit drug trafficking.</p>
<p currentId="doc_1__tblock_1.1__p_15">In relation to new psychoactive substances on which the EU has not
acted, Member States may introduce national technical regulations,
in full compliance with the EU provisions preventing the emergence
of unjustified barriers to trade<authorialNote currentId="doc_1__authorialNote_9" marker="9" placement="bottom">
<p>Directive 98/34/EC of the European Parliament and of the
Council of 22 June 1998 laying down a procedure for the
provision of information in the field of technical standards
and regulations and of rules on Information Society
Services, OJ L 204, 21.7.1998, p. 37.</p>
</authorialNote>.</p>
</tblock>
<tblock currentId="doc_1__tblock_1.2">
<num>1.2.</num>
<heading currentId="doc_1__tblock_1.2__heading">Legal context</heading>
<p currentId="doc_1__tblock_1.2__p_1">Soon after a borderless internal market was created, and following
the emergence and rapid spread of synthetic drugs, such as
amphetamines and ecstasy, it became clear that the effectiveness of
national actions is limited and that EU action was necessary to
contain the spread of harmful substances. The EU Joint Action
97/396/JHA concerning the information exchange, risk assessment and
the control of new synthetic drugs<authorialNote currentId="doc_1__authorialNote_10" marker="10" placement="bottom">
<p>OJ L 167, 25.6.1997, p.1.</p>
</authorialNote>was adopted in 1997 to address this problem.</p>
<p currentId="doc_1__tblock_1.2__p_2">Council Decision 2005/387/JHA, which repealed Joint Action
97/396/JHA, established an EU-wide system for tackling new
psychoactive substances (synthetic and natural) that raise concern
at EU level. It lays down rules on the exchange of information on
these substances between Member States, coordinated by the EMCDDA
and Europol, on the assessment of their risks and the submission to
control and criminal penalties across the EU of those substances
that pose risks.</p>
<p currentId="doc_1__tblock_1.2__p_3">The Commission's assessment report<authorialNote currentId="doc_1__authorialNote_11" marker="11" placement="bottom">
<p>COM(2011) 430 final and SEC(2011) 912 final.</p>
</authorialNote>of July 2011, concluded that, while Council Decision
2005/387/JHA is a useful instrument, it is inadequate, considering
the scale and complexity of the problem, and it, therefore, requires
revision. This is because it involves a lengthy process, it is
reactive and it lacks options to the submission to control and
criminal penalties.</p>
<p currentId="doc_1__tblock_1.2__p_4">This Regulation replaces Council Decision 2005/387/JHA.</p>
</tblock>
</tblock>
<tblock currentId="doc_1__tblock_2">
<num>2.</num>
<heading currentId="doc_1__tblock_2__heading">RESULTS OF CONSULTATIONS WITH THE
INTERESTED PARTIES AND IMPACT ASSESSMENT</heading>
<tblock currentId="doc_1__tblock_2.1">
<num>2.1.</num>
<heading currentId="doc_1__tblock_2.1__heading">Consultations with interested
parties</heading>
<p currentId="doc_1__tblock_2.1__p_1">Broad stakeholder and expert consultations together with a web-based
public consultation and an external study have informed the
preparatory work for this proposal. The Commission involved all
Member States in the assessment of the functioning of Council
Decision 2005/387/JHA, through written consultation. In the context
of the external study, the Commission collected and examined the
views of a host of national authorities (responsible for drug
legislation, justice and health ministries, health institutes and
law enforcement agencies) and of EU agencies involved in the
implementation of Council Decision 2005/387/JHA. It also collected
and examined the views of international organisations (including the
World Health Organisation), civil society organisations, economic
operators in various markets, research institutes and academic
experts.</p>
<p currentId="doc_1__tblock_2.1__p_2">The survey conducted among Member States in the context of the
assessment report showed that a large number of Member States view
the lack of alternatives to control and criminal penalties in the
current instrument as inadequate and suggest that a wider range of
options should be considered, backed by administrative law.
Moreover, all Member States agreed that swifter action is necessary
to address new psychoactive substances (including temporary
measures) and that the current decision-making process is too
slow.</p>
<p currentId="doc_1__tblock_2.1__p_3">During the two experts' meetings organised by the Commission on 15
December 2011 and 1 March 2012, academic experts and practitioners
stressed that the Council Decision and product safety legislation
are inadequate to tackle the large number of new psychoactive
substances emerging on the market, whose effects and risks are
mostly unknown. They pointed out that new legislation on new
psychoactive substances should be calibrated to the different levels
of risks posed by these substances. Certain participants expressed
concern that too rigorous policy responses (such as blanket
restrictions on entire groups of substances or a wide recourse to
criminal penalties) could have adverse effects. Such adverse effects
include a displacement of substances from the licit to the illicit
market, a replacement of the substances withdrawn from the market
with other substances, possibly even more harmful, and rendering
such substances inaccessible for research.</p>
<p currentId="doc_1__tblock_2.1__p_4">Surveys and interviews were conducted with economic operators which
manufacture such substances for various industrial uses, and with
their trade associations, as well as with those who produce or
distribute new psychoactive substances for recreational use.
Recreational users of new psychoactive substances were also
interviewed.</p>
<p currentId="doc_1__tblock_2.1__p_5">The views of young people (15-24 years' old) were collected through
the 2011 Eurobarometer "Youth attitudes on drugs". Almost half of
respondents (47%) thought that only those substances which are
proved to pose risks to health should be restricted, while 34% held
that all substances which imitate the effects of controlled drugs
should be restricted.</p>
<p currentId="doc_1__tblock_2.1__p_6">The Commission run a public consultation on drugs policy from 28
October 2011 to 3 February 2012. It included a question on
regulatory measures that the EU should develop to contain the spread
of new psychoactive substances. Among the 134 replies, most stressed
the need for more rapid action on new psychoactive substances and
warned against imposing criminal sanctions indiscriminately. The
European Economic and Social Committee has urged<authorialNote currentId="doc_1__authorialNote_12" marker="12" placement="bottom">
<p>OJ C 229, 31.7.2012, p. 85.</p>
</authorialNote>the Commission to explore options that avoid making
the personal use of such substances a criminal offence.</p>
</tblock>
<tblock currentId="doc_1__tblock_2.2">
<num>2.2.</num>
<heading currentId="doc_1__tblock_2.2__heading">Impact Assessment</heading>
<blockList currentId="doc_1__tblock_2.2__lst_1">
<listIntroduction currentId="doc_1__tblock_2.2__lst_1__intro">The
Commission conducted an impact assessment of policy
alternatives, taking into account the consultation of interested
parties and the results of external studies. The impact
assessment concluded that the following solution would be
preferred:</listIntroduction>
<item currentId="doc_1__tblock_2.2__lst_1__item_1">
<num>â??</num>
<p>a more graduated and better targeted set of restriction
measures on new psychoactive substances, which should not
hinder the industrial use of substances.</p>
</item>
<item currentId="doc_1__tblock_2.2__lst_1__item_2">
<num>â??</num>
<p>restriction measures should be introduced earlier and
substances suspected to pose immediate public health risks
should be subjected to temporary restrictions.</p>
</item>
<item currentId="doc_1__tblock_2.2__lst_1__item_3">
<num>â??</num>
<p>restriction measures should be proportionate to a better
determined level of risk of substances, with substances
posing moderate risks subjected to restrictions on the
consumer market (covered by administrative law), while
substances posing severe risks should be subjected to a
wider market restriction, as well as being covered by
criminal law.</p>
</item>
<item currentId="doc_1__tblock_2.2__lst_1__item_4">
<num>â??</num>
<p>restriction measures should be introduced through a quicker
procedure.</p>
</item>
</blockList>
<p>The impact assessment concluded that the most effective way to keep
harmful new psychoactive substances out of the market is to apply
the EU provisions on illicit drug trafficking to new psychoactive
substances that pose severe risks. Applying the same criminal law
provisions to controlled drugs and to equally harmful new
psychoactive substances, posing severe risks, will help deter
trafficking in such substances and the involvement of criminal
groups, while streamlining and clarifying the EU legal framework on
drugs.</p>
</tblock>
</tblock>
<tblock currentId="doc_1__tblock_3">
<num>3.</num>
<heading currentId="doc_1__tblock_3__heading">LEGAL ELEMENTS OF THE PROPOSAL</heading>
<tblock currentId="doc_1__tblock_3.1">
<num>3.1.</num>
<heading currentId="doc_1__tblock_3.1__heading">The legal base</heading>
<p>The proposal aims at ensuring that trade in new psychoactive
substances having industrial and commercial uses is not hindered and
that the functioning of this market is improved, while the health
and safety of individuals are protected from harmful substances,
which cause concern at the EU level.</p>
<blockList currentId="doc_1__tblock_3.1__lst_1">
<listIntroduction currentId="doc_1__tblock_3.1__lst_1__intro">The
proposal is based on Article 114 of the Treaty on the
Functioning of the European Union (TFEU), which empowers the
European Parliament and the Council to adopt measures for the
approximation of the provisions laid down by law, regulation or
administrative action in the Member States which have as their
object the establishment and functioning of the internal market.
Article 114(3) TFEU requires the Commission to ensure a high
level of health, safety and consumer protection in its proposals
envisaged in paragraph 1 of Article 114 TFEU. This proposal
falls within the scope of action to improve the functioning of
the internal market for the following
reasons:</listIntroduction>
<item currentId="doc_1__tblock_3.1__lst_1__item_1">
<num>â??</num>
<p>it addresses obstacles to trade in new psychoactive
substances having dual uses, while enabling the adoption of
measures to restrict the availability to consumers of
substances posing risks.</p>
</item>
<item currentId="doc_1__tblock_3.1__lst_1__item_2">
<num>â??</num>
<p>it addresses the lack of legal certainty for economic
operators by harmonising the response given to substances
causing concern across the EU.</p>
</item>
<item currentId="doc_1__tblock_3.1__lst_1__item_3">
<num>â??</num>
<p>it connects the market for industrial uses of new
psychoactive substances to the wider internal market.</p>
</item>
</blockList>
</tblock>
<tblock currentId="doc_1__tblock_3.2">
<num>3.2.</num>
<heading currentId="doc_1__tblock_3.2__heading">Subsidiarity, proportionality
and the respect for fundamental rights</heading>
<p currentId="doc_1__tblock_3.2__p_1">There is a clear need for EU action on new psychoactive substances.
This is because Member States alone cannot reduce the problems
caused by the spread in the internal market of harmful new
psychoactive substances and by the proliferation of divergent
national responses. Uncoordinated national action in this area can
produce adverse knock-on effects, for instance hindrance to the
operation of the internal market as far as licit trade in these
substances is concerned or displacement of harmful substances from
one Member State to another.</p>
<p currentId="doc_1__tblock_3.2__p_2">Consequently, EU-level action is necessary to ensure that potentially
harmful new psychoactive substances, which cause EU-wide concern,
can be identified, assessed and, if they pose risks, withdrawn from
the market rapidly in all Member States.</p>
<p currentId="doc_1__tblock_3.2__p_3">The proposal is relevant for the following rights and principles
enshrined in the EU Charter of Fundamental Rights: the right to
health care (notably to a high level of human health protection,
Article 35) and to consumer protection (Article 38), the respect of
the freedom to conduct a business (Article 16), the right to
property (Article 17), the right to an effective remedy and to a
fair trial (Article 47), the presumption of innocence and right to
defence (Article 48). These rights and freedoms can be subject to
limitations, but only under the limits and requirements set by
Article 52(1) of the EU Charter.</p>
<p currentId="doc_1__tblock_3.2__p_4">The proposal is proportionate and does not go beyond what is
necessary to achieve the objectives because it only addresses new
psychoactive substances that are a concern at the EU level and
because it sets out a calibrated, graduated approach, under which
measures are proportionate to the actual risks of substances.</p>
<p currentId="doc_1__tblock_3.2__p_5">Explicit safeguards laid down in the instrument itself guarantee that
any person whose rights are affected by the implementation of any
administrative measures or sanctions pursuant to the Regulation
shall have the right to an effective remedy before a tribunal.</p>
</tblock>
<tblock currentId="doc_1__tblock_3.3">
<num>3.3.</num>
<heading currentId="doc_1__tblock_3.3__heading">Choice of instrument</heading>
<p>In order to establish uniform rules, ensure clarity of concepts and
procedures, and provide legal certainty for market operators, while
ensuring that restriction measures are directly applicable in all
Member States, a Regulation is the appropriate instrument.</p>
</tblock>
<tblock currentId="doc_1__tblock_3.4">
<num>3.4</num>
<heading currentId="doc_1__tblock_3.4__heading">Specific provisions</heading>
<p currentId="doc_1__tblock_3.4__p_1"><i currentId="doc_1__tblock_3.4__p_1__i_1">Article 1: Subject matter and scope</i> â?? this provision sets out
the purpose and scope of the proposal, and in particular that it
establishes rules for restrictions to the free movement of new
psychoactive substances in the internal market.</p>
<p currentId="doc_1__tblock_3.4__p_2"><i currentId="doc_1__tblock_3.4__p_2__i_1">Article 2: Definitions</i> â?? this provision sets out definitions
which apply throughout the instrument.</p>
<p currentId="doc_1__tblock_3.4__p_3"><i currentId="doc_1__tblock_3.4__p_3__i_1">Article 3: Free movement</i> â?? this provision lays down the
principle of free movement of new psychoactive substances for
industrial and commercial uses, and for research and
development.</p>
<p currentId="doc_1__tblock_3.4__p_4"><i currentId="doc_1__tblock_3.4__p_4__i_1">Article 4: Prevention of barriers to free movement</i> â?? this
provision clarifies under what conditions Member States may
introduce restrictions on new psychoactive substances.</p>
<p currentId="doc_1__tblock_3.4__p_5"><i currentId="doc_1__tblock_3.4__p_5__i_1">Article 5: Information exchange</i> â?? this provision establishes
the respective roles of Member States, the EMCDDA and Europol in the
process of exchange of information on new psychoactive
substances.</p>
<p currentId="doc_1__tblock_3.4__p_6"><i currentId="doc_1__tblock_3.4__p_6__i_1">Article 6: Joint report</i> â?? this provision lays down the
contents and the procedures for the drawing up and the transmission
by the EMCDDA and Europol of a joint report on a new psychoactive
substance. The Commission, the European Medicines Agency, the
European Chemicals Agency and the European Food Safety Authority are
associated to the collection of information for a joint report.</p>
<p currentId="doc_1__tblock_3.4__p_7"><i currentId="doc_1__tblock_3.4__p_7__i_1">Article 7: Risk assessment procedure and report</i> â?? this
provision empowers the Commission to request the EMCDDA to assess
the risks of a new psychoactive substance on which a joint report
was drawn up. It lays down the procedures for the risk assessment,
which is to be conducted by the Scientific Committee of the EMCDDA,
and for the drawing up and the transmission of a risk assessment
report.</p>
<p currentId="doc_1__tblock_3.4__p_8"><i currentId="doc_1__tblock_3.4__p_8__i_1">Article 8: Exclusion from risk assessment</i> â?? this provision
details such circumstances in which no risk assessment is to be
conducted on a new psychoactive substance.</p>
<p currentId="doc_1__tblock_3.4__p_9"><i currentId="doc_1__tblock_3.4__p_9__i_1">Article 9: Immediate risks to public health and temporary consumer
market restriction</i> â?? this provision lays down the criteria
on the basis of which the Commission determines whether a new
psychoactive substance poses immediate risks to public health, and
empowers the Commission to prohibit, temporarily, the making
available of this substance on the consumer market, if it poses such
immediate risks to public health.</p>
<p currentId="doc_1__tblock_3.4__p_10"><i currentId="doc_1__tblock_3.4__p_10__i_1">Article 10: Determination of the level of health, social and
safety risks following the risk assessment</i> â?? this provision
lays down the criteria on the basis of which the Commission
determines the level of health, social and safety risks posed by a
new psychoactive substance.</p>
<p currentId="doc_1__tblock_3.4__p_11"><i currentId="doc_1__tblock_3.4__p_11__i_1">Article 11: Low risks</i> â?? this provision sets out that the
Commission shall introduce no restriction measures on new
psychoactive substances posing low health, social and safety risks
and provides a definition of low risks.</p>
<p currentId="doc_1__tblock_3.4__p_12"><i currentId="doc_1__tblock_3.4__p_12__i_1">Article 12: Moderate risks and permanent consumer market
restriction</i> â?? this provision empowers the Commission to
prohibit the making available on the consumer market of new
psychoactive substances which pose moderate health, social and
safety risks, and provides a definition of moderate risks.</p>
<p currentId="doc_1__tblock_3.4__p_13"><i currentId="doc_1__tblock_3.4__p_13__i_1">Article 13: Severe risks and permanent market restriction</i> â??
this provision empowers the Commission to prohibit the production,
manufacture, making available on the market, transport, importation
or exportation of new psychoactive substances which pose severe
health, social and safety risks, and provides a definition of severe
risks.</p>
<p currentId="doc_1__tblock_3.4__p_14"><i currentId="doc_1__tblock_3.4__p_14__i_1">Article 14: Authorised uses</i> â?? this provision sets out the
exceptions to the market restrictions introduced under the
Regulation.</p>
<p currentId="doc_1__tblock_3.4__p_15"><i currentId="doc_1__tblock_3.4__p_15__i_1">Article 15: Monitoring</i> â?? this provision lays down monitoring
obligations with regard to substances on which a joint report has
been drawn up.</p>
<p currentId="doc_1__tblock_3.4__p_16"><i currentId="doc_1__tblock_3.4__p_16__i_1">Article 16: Re-examination of the level of risks</i> â?? this
provision sets out the procedure for re-examining the level of risks
posed by a new psychoactive substance in the light of new
information and evidence on the substance.</p>
<p currentId="doc_1__tblock_3.4__p_17"><i currentId="doc_1__tblock_3.4__p_17__i_1">Article 17: Sanctions</i> â?? this provision establishes the
obligation for the Member States to lay down the rules on
administrative sanctions applicable to infringements to market
restriction, and to ensure that they are effective, proportionate
and dissuasive.</p>
<p currentId="doc_1__tblock_3.4__p_18"><i currentId="doc_1__tblock_3.4__p_18__i_1">Article 18: Remedy</i> â?? this provision sets out the right to an
effective judicial remedy enshrined in Article 47 of the Charter of
Fundamental Rights.</p>
<p currentId="doc_1__tblock_3.4__p_19"><i currentId="doc_1__tblock_3.4__p_19__i_1">Articles 19: Committee</i> â?? this provision lays down the standard
rules for the exercise of implementing powers in line with Article
291 TFEU.</p>
<p currentId="doc_1__tblock_3.4__p_20"><i currentId="doc_1__tblock_3.4__p_20__i_1">Article 20: Research and analysis</i> â?? this provision describes
the ways in which the EU shall support the development, sharing and
dissemination of information and knowledge on new psychoactive
substances, to support the rapid exchange of information on and risk
assessment of new psychoactive substances.</p>
<p currentId="doc_1__tblock_3.4__p_21"><i currentId="doc_1__tblock_3.4__p_21__i_1">Article 21: Reportin</i>g â?? this provision requests the EMCDDA and
Europol to report annually on the implementation of certain aspects
of the Regulation.</p>
<p currentId="doc_1__tblock_3.4__p_22"><i currentId="doc_1__tblock_3.4__p_22__i_1">Article 22: Evaluation</i> â?? this provision sets out an obligation
for the Commission to regularly assess the implementation,
application and effectiveness of this Regulation and to report to
the European Parliament and Council.</p>
<p currentId="doc_1__tblock_3.4__p_23"><i currentId="doc_1__tblock_3.4__p_23__i_1">Article 23: Replacement of Decision 2005/387/JHA</i> â?? this
provision sets out that this Regulation replaces Council Decision
2005/387/JHA.</p>
<p currentId="doc_1__tblock_3.4__p_24"><i currentId="doc_1__tblock_3.4__p_24__i_1">Article 24: Entry into force</i> â?? this establishes when the
Regulation shall enter into force.</p>
</tblock>
</tblock>
<tblock currentId="doc_1__tblock_4">
<num>4.</num>
<heading currentId="doc_1__tblock_4__heading">BUDGETARY IMPLICATION</heading>
<p>The proposal has no direct impact on the EU budget and does not create
new tasks for the EMCDDA, Europol, the European Medicines Agencies, the
European Chemicals Agency (ECHA) and the European Food Safety Authority
(EFSA). For the purpose of this Regulation, the ECHA and the EFSA are
only required to share the information at their disposal, on a limited
number of substances, and are not requested to produce new
information.</p>
</tblock>
</mainBody>
</doc>
</component>
<component currentId="component_2">
<bill name="regulation" contains="originalVersion">
<meta>
<identification source="#parisse">
<FRBRWork>
<FRBRthis currentId="bill_1__component_2__FRBRWork__FRBRthis" value="/eu/bill/regulation/2013-09-17/619/main"/>
<FRBRuri currentId="bill_1__component_2__FRBRWork__FRBRuri" value="/eu/bill/regulation/2013-09-17/619"/>
<FRBRalias currentId="bill_1__component_2__FRBRWork__FRBRalias_1" name="xml4ep:/doc/idSchema/COMnumber" value="COM(2013) 619"/>
<FRBRdate currentId="bill_1__component_2__FRBRWork__FRBRdate_1" date="2013-09-17" name="instantiation"/>
<FRBRauthor currentId="bill_1__component_2__FRBRWork__FRBRauthor_1" href="eu.europa.europarl.codict:institution/id=27" as="xml4ep:/role/procedure/legislativePower"/>
<FRBRauthor currentId="bill_1__component_2__FRBRWork__FRBRauthor_2" href="/ontology/organisation/europeanInstitution/commission" as="xml4ep:/ontology/role/procedure/legislativePower"/>
<FRBRcountry currentId="bill_1__component_2__FRBRWork__FRBRcountry" value="eu"/>
<FRBRprescriptive currentId="bill_1__component_2__FRBRWork__FRBRprescriptive" value="true"/>
<FRBRauthoritative currentId="bill_1__component_2__FRBRWork__FRBRauthoritative" value="true"/>
</FRBRWork>
<FRBRExpression>
<FRBRthis currentId="bill_1__component_2__FRBRExpression__FRBRthis" value="/eu/bill/regulation/2013-09-17/619/en@main"/>
<FRBRuri currentId="bill_1__component_2__FRBRExpression__FRBRuri" value="/eu/bill/regulation/2013-09-17/619/en@"/>
<FRBRalias currentId="bill_1__component_2__FRBRExpression__FRBRalias_1" name="xml4ep:/doc/idSchema/COMnumberVersion" value="COM(2013) 619 final"/>
<FRBRdate currentId="bill_1__component_2__FRBRExpression__FRBRdate_1" date="2013-09-17" name="instantiation"/>
<FRBRauthor currentId="bill_1__component_2__FRBRExpression__FRBRauthor_1" href="eu.europa.europarl.codict:institution/id=10" as="xml4ep:role/procedure/initiativeRight"/>
<FRBRlanguage currentId="bill_1__component_2__FRBRExpression__FRBRlanguage_1" language="en"/>
</FRBRExpression>
<FRBRManifestation>
<FRBRthis currentId="bill_1__component_2__FRBRManifestation__FRBRthis" value="/eu/bill/regulation/2013-09-17/619/en@main/.xml"/>
<FRBRuri currentId="bill_1__component_2__FRBRManifestation__FRBRuri" value="/eu/bill/regulation/2013-09-17/619/en@.akn"/>
<FRBRdate currentId="bill_1__component_2__FRBRManifestation__FRBRdate_1" date="2013-09-17" name="instantiation"/>
<FRBRauthor currentId="bill_1__component_2__FRBRManifestation__FRBRauthor_1" href="#parisse" as="#poc"/>
</FRBRManifestation>
</identification>
<analysis source="#parisse">
<activeModifications>
<efficacyMod currentId="bill_1__component_2__analysis_1__activeModifications_1__efficacyMod_1" type="endOfEfficacy">
<source currentId="bill_1__component_2__analysis_1__activeModifications_1__efficacyMod_1__source_1" href="bill_1__#art_23"/>
<destination currentId="bill_1__component_2__analysis_1__activeModifications_1__efficacyMod_1__destination_1" href="/eu/act/decision/2005/387/JHA"/>
</efficacyMod>
</activeModifications>
</analysis>
<references source="#parisse">
<TLCTerm currentId="bill_1__newPsychoactiveSubstance" href="/ontology/term/newPsychoactiveSubstance" showAs="new psychoactive substance"/>
<TLCTerm currentId="bill_1__mixture" href="/ontology/term/mixture" showAs="mixture"/>
<TLCTerm currentId="bill_1__medicinalProduct" href="/ontology/term/medicinalProduct" showAs="medicinal product"/>
<TLCTerm currentId="bill_1__veterinaryMedicinalProduct" href="/ontology/term/veterinaryMedicinalProduct" showAs="veterinary medicinal product"/>
<TLCTerm currentId="bill_1__marketingAuthorisation" href="/ontology/term/marketingAuthorisation" showAs="marketing authorisation"/>
<TLCTerm currentId="bill_1__makingAvailableOnTheMarket" href="/ontology/term/makingAvailableOnTheMarket" showAs="making available on the market"/>
<TLCTerm currentId="bill_1__consumer" href="/ontology/term/consumer" showAs="consumer"/>
<TLCTerm currentId="bill_1__commercialAndIndustrialUse" href="/ontology/term/commercialAndIndustrialUse" showAs="commercial and industrial use"/>
<TLCTerm currentId="bill_1__scientificResearchAndDevelopment" href="/ontology/term/scientificResearchAndDevelopment" showAs="scientific research and development"/>
<TLCTerm currentId="bill_1__unitedNationsSystem" href="/ontology/term/unitedNationsSystem" showAs="United Nations System"/>
<TLCProcess currentId="bill_1__COD" href="/ontology/process/COD" showAs="ordinary legislative procedure"/>
</references>
</meta>
<preface currentId="bill_1__preface">
<container currentId="bill_1__preface__container_1" name="relatedProc">
<p>2013/0305 (COD)</p>
</container>
<longTitle currentId="bill_1__preface__ltti_1">
<p>
<docTitle currentId="bill_1__preface__ltti_1__p_1__docTitle_1"><docStage currentId="bill_1__preface__ltti_1__p_1__docTitle_1__docStage_1">Proposal for
a</docStage><docType currentId="bill_1__preface__ltti_1__p_1__docTitle_1__docType_1">REGULATION</docType>
<docAuthority currentId="bill_1__preface__ltti_1__p_1__docTitle_1__docAuthority_1">OF THE EUROPEAN PARLIAMENT AND OF THE
COUNCIL</docAuthority>
<docPurpose currentId="bill_1__preface__ltti_1__p_1__docTitle_1__docPurpose_1">on new psychoactive substances</docPurpose>(Text with
EEA relevance)</docTitle>
</p>
</longTitle>
</preface>
<preamble currentId="bill_1__preamble">
<formula currentId="bill_1__preamble__formula_1" name="authority">
<p>THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE EUROPEAN UNION,</p>
</formula>
<citations currentId="bill_1__cits_1">
<citation currentId="bill_1__cits_1__cit_1">
<p>Having regard to the <ref currentId="bill_1__cits_1__cit_1__p_1__ref_1" href="/eu/act/treaty/TFEU#art114">Treaty on the Functioning of
the European Union, and in particular Article 114</ref>
thereof,</p>
</citation>
<citation currentId="bill_1__cits_1__cit_2">
<p>Having regard to the proposal from the European Commission,</p>
</citation>
<citation currentId="bill_1__cits_1__cit_3">
<p>After transmission of the draft legislative act to the national
parliaments,</p>
</citation>
<citation currentId="bill_1__cits_1__cit_4">
<p>Having regard to the opinion of the European Economic and Social
Committee<authorialNote currentId="bill_1__authorialNote_13" marker="13" placement="bottom">
<p>OJ C [â?¦], [â?¦], p. [â?¦].</p>
</authorialNote>,</p>
</citation>
<citation currentId="bill_1__cits_1__cit_5">
<p>Acting in accordance with the <process currentId="bill_1__cits_1__cit_5__p_1__process_1" refersTo="#bill_1__COD">ordinary
legislative procedure</process>,</p>
</citation>
</citations>
<recitals currentId="bill_1__recs_1">
<intro currentId="bill_1__recs_1__intro">
<p>Whereas:</p>
</intro>
<recital currentId="bill_1__recs_1__rec_1">
<num>(1)</num>
<p>New psychoactive substances, which may have numerous commercial and
industrial uses, as well as scientific uses, can pose health, social
and safety risks when consumed by humans.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_2">
<num>(2)</num>
<p>During the past years, Member States have notified an increasing
number of new psychoactive substances via the mechanism for rapid
exchange of information which was established by Joint Action
97/396/JHA of 16 June 1997 adopted by the Council on the basis of
Article K.3 of the Treaty on European Union, concerning the
information exchange, risk assessment and the control of new
synthetic drugs<authorialNote currentId="bill_1__authorialNote_14" marker="14" placement="bottom">
<p>OJ L 167, 25.6.1997, p. 1.</p>
</authorialNote>and was further strengthened by the <ref currentId="bill_1__recs_1__rec_2__p_1__ref_1" href="/eu/act/decision/2005/387/JHA">Council Decision
2005/387/JHA of 10 May 2005 on the information exchange,
risk-assessment and control of new psychoactive
substances</ref><authorialNote currentId="bill_1__authorialNote_15" marker="15" placement="bottom">
<p>OJ L 127, 20.5.2005, p. 32.</p>
</authorialNote>. A large majority of these new psychoactive
substances were reported by more than one Member State. Many such
new psychoactive substances were sold to consumers without
appropriate labelling and instructions of use.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_3">
<num>(3)</num>
<p>Member States' competent public authorities introduce various
restriction measures on these new psychoactive substances to address
the risks that they pose or may pose when consumed. As new
psychoactive substances are often used in the production of various
goods or of other substances which are used for manufacturing goods,
such as medicines, industrial solvents, cleaning agents, goods in
the hi-tech industry, restricting their access for this use can have
an important impact on economic operators, potentially disrupting
their business activities in the internal market.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_4">
<num>(4)</num>
<p>The increasing number of new psychoactive substances available in the
internal market, their growing diversity, the speed with which they
emerge on the market, the different risks that they may pose when
consumed by humans and the growing number of individuals who consume
them, challenge the capacity of public authorities to provide
effective responses to protect public health and safety without
hampering the functioning of the internal market.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_5">
<num>(5)</num>
<p>Restriction measures vary significantly in different Member States,
meaning that economic operators that use them in the production of
various goods must comply, in the case of the same new psychoactive
substance, with different requirements, such as pre-export
notification, export authorisation, or import and export licences.
Consequently, the differences between the Member States' laws,
regulations and administrative provisions on new psychoactive
substances hinder the functioning of the internal market, by causing
obstacles to trade, market fragmentation, lack of legal clarity and
of an even level playing field for economic operators, making it
difficult for companies to operate across the internal market.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_6">
<num>(6)</num>
<p>Restriction measures not only cause barriers to trade in the case of
new psychoactive substances that already have commercial, industrial
or scientific uses, but can also impede the development of such
uses, and are likely to cause obstacles to trade for economic
operators that seek to develop such uses, by making access to those
new psychoactive substances more difficult.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_7">
<num>(7)</num>
<p>The disparities between the various restriction measures applied to
new psychoactive substances can also lead to displacement of harmful
new psychoactive substances between the Member States, hampering
efforts to restrict their availability to consumers and undermining
consumer protection across the Union.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_8">
<num>(8)</num>
<p>Such disparities are expected to increase as Member States continue
to pursue divergent approaches to addressing new psychoactive
substances. Therefore, the obstacles to trade and market
fragmentation, and the lack of legal clarity and of a level playing
field are expected to increase, further hindering the functioning of
the internal market.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_9">
<num>(9)</num>
<p>Those distortions to the functioning of the internal market should be
eliminated and, to that end, the rules relating to new psychoactive
substances that are of concern at Union level should be
approximated, while, at the same time, ensuring a high level of
health, safety and consumer protection.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_10">
<num>(10)</num>
<p>New psychoactive substances and mixtures should be able to move
freely in the Union when intended for commercial and industrial use,
as well as for scientific research and development. This Regulation
should establish rules for introducing restrictions to this free
movement.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_11">
<num>(11)</num>
<p>New psychoactive substances that pose health, social and safety risks
across the Union should be addressed at the Union level. Action on
new psychoactive substances under this Regulation should contribute
to a high level of protection of human health and safety, as
enshrined in the Charter of Fundamental Rights of the European
Union.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_12">
<num>(12)</num>
<p>This Regulation should not apply to drug precursors because the
diversion of those chemical substances for the purpose of
manufacturing narcotic drugs or psychotropic substances is addressed
under <ref currentId="bill_1__recs_1__rec_12__p_1__ref_1" href="/eu/act/regulation/2004/273">Regulation (EC) No 273/2004
of the European Parliament and of the Council of 11 February
2004 on drug precursors</ref><authorialNote currentId="bill_1__authorialNote_16" marker="16" placement="bottom">
<p>OJ L 47, 18.2.2004, p. 1.</p>
</authorialNote>and <ref currentId="bill_1__recs_1__rec_12__p_1__ref_2" href="/eu/act/regulation/2005/111">Council Regulation (EC) No
111/2005 of 22 December 2004 laying down rules for the
monitoring of trade between the Community and third countries in
drug precursors</ref><authorialNote currentId="bill_1__authorialNote_17" marker="17" placement="bottom">
<p>OJ L 22, 26.1.2005, p. 1.</p>
</authorialNote>.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_13">
<num>(13)</num>
<p>Any Union action on new psychoactive substances should be based on
scientific evidence and subject to a specific procedure. Based on
the information notified by Member States, a report should be drawn
up on new psychoactive substances that give rise to concerns across
the Union. The report should indicate whether it is necessary to
carry out a risk assessment. Following the risk assessment, the
Commission should determine whether the new psychoactive substances
should be subjected to any restriction measures. In case of
immediate public health concerns, the Commission should subject them
to temporary consumer market restriction before the conclusion of
the risk assessment. In case new information emerges on a new
psychoactive substance, the Commission should re-assess the level of
risks that it poses. Reports on new psychoactive substances should
be made publicly available.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_14">
<num>(14)</num>
<p>No risk assessment should be conducted under this Regulation on a new
psychoactive substance if it is subject to an assessment under
international law, or if it is an active substance in a medicinal
product or in a veterinary medicinal product.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_15">
<num>(15)</num>
<p>Where the new psychoactive substance on which a report is drawn up is
an active substance in a medicinal product or in a veterinary
medicinal product, the Commission should assess with the European
Medicines Agency the need for further action.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_16">
<num>(16)</num>
<p>The measures taken on new psychoactive substances at Union level
should be proportionate to the health, social and safety risks that
they pose.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_17">
<num>(17)</num>
<p>Certain new psychoactive substances pose immediate public health
risks, requiring urgent action. Therefore, their availability to
consumers should be restricted for a limited time, pending their
risk assessment.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_18">
<num>(18)</num>
<p>No restriction measures should be introduced at Union level on new
psychoactive substances which pose low health, social and safety
risks.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_19">
<num>(19)</num>
<p>Those new psychoactive substances which pose moderate health, social
and safety risks should not be made available to consumers.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_20">
<num>(20)</num>
<p>Those new psychoactive substances which pose severe health, social
and safety risks should not be made available on the market.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_21">
<num>(21)</num>
<p>This Regulation should provide for exceptions in order to ensure the
protection of human and animal health, to facilitate scientific
research and development, and to allow the use of new psychoactive
substances in industry, provided that they cannot be abused or
recovered.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_22">
<num>(22)</num>
<p>In order to ensure the efficient implementation of this Regulation,
the Member States should lay down rules on the sanctions applicable
to infringements of restriction measures. Those sanctions should be
effective, proportionate and dissuasive.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_23">
<num>(23)</num>
<p>The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
established by Regulation 1920/2006/EC of the European Parliament
and of the Council of 12 December 2006<authorialNote currentId="bill_1__authorialNote_18" marker="18" placement="bottom">
<p>OJ L 376, 27.12.2006, p. 1.</p>
</authorialNote>should have a central role in the exchange of
information on new psychoactive substances and in the assessment of
the health, social and safety risks that they pose.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_24">
<num>(24)</num>
<p>The mechanism for rapid exchange of information on new psychoactive
substances has proved to be a useful channel for sharing information
on new psychoactive substances, on new trends in the use of
controlled psychoactive substances and on related public health
warnings. That mechanism should be further strengthened to enable a
more effective response to the rapid emergence and spread of new
psychoactive substances across the Union.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_25">
<num>(25)</num>
<p>Information from Member States is crucial for the effective
functioning of the procedures leading to decision on market
restriction of new psychoactive substances. Therefore, Member States
should collect, on a regular basis, data on the use of new
psychoactive substances, related health, safety and social problems
and policy responses, in accordance with the EMCDDA framework for
data collection for the key epidemiological indicators and other
relevant data. They should share this data.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_26">
<num>(26)</num>
<p>A lack of capacity to identify and anticipate the emergence and
spread of new psychoactive substances and a lack of evidence about
their health, social and safety risks hamper the provision of an
effective response. Therefore, support should be provided, including
at Union level, to facilitate cooperation between the EMCDDA,
research institutes and forensic laboratories with relevant
expertise, in order to increase the capacity to assess and address
effectively new psychoactive substances.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_27">
<num>(27)</num>
<p>The procedures for information exchange, risk assessment and adoption
of temporary and permanent restriction measures on new psychoactive
substances established by this Regulation should enable swift
action. Market restriction measures should be adopted without undue
delay, not later than eight weeks from receipt of the joint report
or risk assessment report.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_28">
<num>(28)</num>
<p>As long as the Union has not adopted measures to subject a new
psychoactive substance to market restriction under this Regulation,
Member States may adopt technical regulations on that new
psychoactive substance in compliance with the provisions of
Directive 98/34/EC of the European Parliament and of the Council of
22 June 1998 laying down a procedure for the provision of
information in the field of technical standards and regulations and
of rules on Information Society Services<authorialNote currentId="bill_1__authorialNote_19" marker="19" placement="bottom">
<p>OJ L 204, 21.7.1998. p. 37.</p>
</authorialNote>. In order to preserve the unity of the Union's
internal market and to prevent the emergence of unjustified barriers
to trade, Member States should immediately communicate to the
Commission any draft technical regulation on new psychoactive
substances, in accordance with the procedure established by
Directive 98/34/EC.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_29">
<num>(29)</num>
<p>Prevention, treatment and harm reduction measures are important for
addressing the growing use of new psychoactive substances and their
potential risks. The internet, which is one of the important
distribution channels through which new psychoactive substances are
sold, should be used for disseminating information on the health,
social and safety risks that they pose.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_30">
<num>(30)</num>
<p>Medicinal products and veterinary medicinal products are addressed
under Directive 2001/82/EC of the European Parliament and of the
Council of 6 November 2001 on the Community code relating to
veterinary medicinal products<authorialNote currentId="bill_1__authorialNote_20" marker="20" placement="bottom">
<p>OJ L 311, 28.11.2001, p. 67.</p>
</authorialNote>, Directive 2001/83/EC of the European Parliament
and of the Council of 6 November 2001 on the Community code relating
to medicinal products for human use<authorialNote currentId="bill_1__authorialNote_21" marker="21" placement="bottom">
<p>OJ L 311, 28.11.2001, p. 1.</p>
</authorialNote>and Regulation (EC) No 726/2004 of the European
Parliament and of the Council of 31 March 2004 laying down Community
procedures for the authorisation and supervision of medicinal
products for human and veterinary use and establishing a European
Medicines Agency<authorialNote currentId="bill_1__authorialNote_22" marker="22" placement="bottom">
<p>OJ L 136, 30.4.2004, p. 1.</p>
</authorialNote>. Their abuse or misuse should, therefore, not be
covered by this Regulation.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_31">
<num>(31)</num>
<p>In order to ensure uniform conditions for the implementation of
temporary and permanent market restrictions, implementing powers
should be conferred on the Commission. Those powers should be
exercised in accordance with Regulation (EU) No 182/2011 of the
European Parliament and of the Council of 16 February 2011 laying
down the rules and general principles concerning mechanisms for
control by the Member States of the Commission's exercise of
implementing powers<authorialNote currentId="bill_1__authorialNote_23" marker="23" placement="bottom">
<p>OJ L 55, 28.02.2011, p.13.</p>
</authorialNote>.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_32">
<num>(32)</num>
<p>The Commission should adopt immediately applicable implementing acts
where, in duly justified cases relating to a rapid increase in the
number of reported fatalities in several Member States associated
with the consumption of the new psychoactive substance concerned,
imperative grounds of urgency so require.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_33">
<num>(33)</num>
<p>In the application of this Regulation, the Commission should consult
Member States' experts, relevant Union agencies, civil society and
economic operators.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_34">
<num>(34)</num>
<p>Since the objectives of the proposed action cannot be sufficiently
achieved by the Member States, and can therefore, by reason of the
effects of the envisaged action, be better achieved at the Union
level, the Union may adopt measures, in accordance with the
principle of subsidiarity as set out in Article 5 of the Treaty on
European Union. In accordance with the principle of proportionality
as set out in that Article, this Regulation does not go beyond what
is necessary in order to achieve those objectives.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_35">
<num>(35)</num>
<p>In order to establish uniform rules and ensure clarity of concepts
and procedures, as well as to provide legal certainty for economic
operators, it is appropriate to adopt this act in the form of a
Regulation.</p>
</recital>
<recital currentId="bill_1__recs_1__rec_36">
<num>(36)</num>
<p>This Regulation respects fundamental rights and observes the
principles recognised by the Charter of Fundamental Rights of the
European Union, including the freedom to conduct a business, the
right to property and the right to an effective remedy,</p>
</recital>
</recitals>
<formula currentId="bill_1__preamble__formula_2" name="adoption">
<p>HAVE ADOPTED THIS REGULATION:</p>
</formula>
</preamble>
<body currentId="bill_1__body">
<chapter currentId="bill_1__body__chp_I">
<num>CHAPTER I</num>
<heading currentId="bill_1__body__chp_I__heading">Subject matter - Scope -
Definitions</heading>
<article currentId="bill_1__art_1">
<num>Article 1</num>
<heading currentId="bill_1__art_1__heading">Subject matter and scope</heading>
<paragraph currentId="bill_1__art_1__par_1">
<num>1.</num>
<content currentId="bill_1__art_1__par_1__content">
<p>This Regulation establishes rules for restrictions to the
free movement of new psychoactive substances in the internal
market. For that purpose it sets up a mechanism for
information exchange on, risk assessment and submission to
market restriction measures of new psychoactive substances
at Union level.</p>
</content>
</paragraph>
<paragraph currentId="bill_1__art_1__par_2">
<num>2.</num>
<content currentId="bill_1__art_1__par_2__content">
<p>This Regulation shall not apply to scheduled substances as
defined in Regulation (EC) No 273/2004 and Regulation (EC)
No 111/2005.</p>
</content>
</paragraph>
</article>
<article currentId="bill_1__art_2">
<num>Article 2</num>
<heading currentId="bill_1__art_2__heading">Definitions</heading>
<list currentId="bill_1__art_2__lst_1">
<intro currentId="bill_1__art_2__lst_1__intro">
<p>For the purpose of this Regulation, the following definitions
apply:</p>
</intro>
<point currentId="bill_1__art_2__lst_1__pnt_a">
<num>(a)</num>
<content currentId="bill_1__art_2__lst_1__pnt_a__content">
<p>â??<term currentId="bill_1__art_2__lst_1__pnt_a__p_1__term_1" refersTo="#bill_1__newPsychoactiveSubstance">new
psychoactive substance</term>â?? means <def currentId="bill_1__art_2__lst_1__pnt_a__p_1__def_1" refersTo="#bill_1__newPsychoactiveSubstance">a natural or
synthetic substance that, when consumed by a human,
has the capacity to produce central nervous system
stimulation or depression, resulting in
hallucinations, alterations in motor function,
thinking, behaviour, perception, awareness or mood,
which is intended for human consumption or is likely
to be consumed by humans even if not intended for
them with the purpose of inducing one or more of the
effects mentioned above, which is neither controlled
under the 1961 United Nations Single Convention on
Narcotic Drugs, as amended by the 1972 Protocol, nor
the 1971 United Nations Convention on Psychotropic
Substances; it excludes alcohol, caffeine and
tobacco, as well as tobacco products within the
meaning of Council Directive 2001/37/EC of 5 June
2001 on the approximation of the laws, regulations
and administrative provisions of the Member States
concerning the manufacture, presentation and sale of
tobacco products<authorialNote currentId="bill_1__authorialNote_24" marker="24" placement="bottom">
<p>OJ L 194, 18.7.2001, p. 26.</p>
</authorialNote>;</def></p>
</content>
</point>
<point currentId="bill_1__art_2__lst_1__pnt_b">
<num>(b)</num>
<content currentId="bill_1__art_2__lst_1__pnt_b__content">
<p>â??<term currentId="bill_1__art_2__lst_1__pnt_b__p_1__term_1" refersTo="#bill_1__mixture">mixture</term>â?? means <def currentId="bill_1__art_2__lst_1__pnt_b__p_1__def_1" refersTo="#bill_1__mixture">a mixture or solution containing
one or more new psychoactive substances</def>;</p>
</content>
</point>
<point currentId="bill_1__art_2__lst_1__pnt_c">
<num>(c)</num>
<content currentId="bill_1__art_2__lst_1__pnt_c__content">
<p>â??<term currentId="bill_1__art_2__lst_1__pnt_c__p_1__term_1" refersTo="#bill_1__medicinalProduct">medicinal
product</term>â?? means <def currentId="bill_1__art_2__lst_1__pnt_c__p_1__def_1" refersTo="#bill_1__medicinalProduct">a product as defined in
<ref currentId="bill_1__art_2__lst_1__pnt_c__p_1__def_1__ref_1" href="/eu/act/directive/2001/83#art_1__pnt_2">point 2 of Article 1 of Directive
2001/83/EC</ref></def>;</p>
</content>
</point>
<point currentId="bill_1__art_2__lst_1__pnt_d">
<num>(d)</num>
<content currentId="bill_1__art_2__lst_1__pnt_d__content">
<p>â??<term currentId="bill_1__art_2__lst_1__pnt_d__p_1__term_1" refersTo="#bill_1__veterinaryMedicinalProduct">veterinary
medicinal product</term>â?? means <def currentId="bill_1__art_2__lst_1__pnt_d__p_1__def_1" refersTo="#bill_1__veterinaryMedicinalProduct">a product as
defined in <ref currentId="bill_1__art_2__lst_1__pnt_d__p_1__def_1__ref_1" href="/eu/act/directive/2001/82#art_1__pnt_2">point 2 of Article 1 of Directive
2001/82/EC</ref></def>;</p>
</content>
</point>
<point currentId="bill_1__art_2__lst_1__pnt_e">
<num>(e)</num>
<content currentId="bill_1__art_2__lst_1__pnt_e__content">
<p>â??<term currentId="bill_1__art_2__lst_1__pnt_e__p_1__term_1" refersTo="#bill_1__marketingAuthorisation">marketing
authorisation</term>â?? means <def currentId="bill_1__art_2__lst_1__pnt_e__p_1__def_1" refersTo="#bill_1__marketingAuthorisation">an authorisation
to place a medicinal product or a veterinary
medicinal product on the market, in accordance with
<ref currentId="bill_1__art_2__lst_1__pnt_e__p_1__def_1__ref_1" href="/eu/act/directive/2001/83">Directive
2001/83/EC</ref>, <ref currentId="bill_1__art_2__lst_1__pnt_e__p_1__def_1__ref_2" href="/eu/act/directive/2001/82">Directive
2001/82/EC</ref> or <ref currentId="bill_1__art_2__lst_1__pnt_e__p_1__def_1__ref_3" href="/eu/act/regulation/2004/726">Regulation (EC)
No 726/2004</ref></def>;</p>
</content>
</point>
<point currentId="bill_1__art_2__lst_1__pnt_f">
<num>(f)</num>
<content currentId="bill_1__art_2__lst_1__pnt_f__content">
<p>â??<term currentId="bill_1__art_2__lst_1__pnt_f__p_1__term_1" refersTo="#bill_1__makingAvailableOnTheMarket">making
available on the market</term>â?? means <def currentId="bill_1__art_2__lst_1__pnt_f__p_1__def_1" refersTo="#bill_1__makingAvailableOnTheMarket">any supply of
a new psychoactive substance for distribution,
consumption or use on the Union market in the course
of a commercial activity, whether in return for
payment or free of charge</def>;</p>
</content>
</point>
<point currentId="bill_1__art_2__lst_1__pnt_g">
<num>(g)</num>
<content currentId="bill_1__art_2__lst_1__pnt_g__content">
<p>â??<term currentId="bill_1__art_2__lst_1__pnt_g__p_1__term_1" refersTo="#bill_1__consumer">consumer</term>â?? means <def currentId="bill_1__art_2__lst_1__pnt_g__p_1__def_1" refersTo="#bill_1__consumer">any natural person who is
acting for purposes which are outside his/her trade,
business or profession</def>;</p>
</content>
</point>
<point currentId="bill_1__art_2__lst_1__pnt_h">
<num>(h)</num>
<content currentId="bill_1__art_2__lst_1__pnt_h__content">
<p>â??<term currentId="bill_1__art_2__lst_1__pnt_h__p_1__term_1" refersTo="#bill_1__commercialAndIndustrialUse">commercial
and industrial use</term>â?? means <def currentId="bill_1__art_2__lst_1__pnt_h__p_1__def_1" refersTo="#bill_1__commercialAndIndustrialUse">any
manufacture, processing, formulation, storage,
mixing, production and sale to natural and legal
persons other than consumers</def>;</p>
</content>
</point>
<point currentId="bill_1__art_2__lst_1__pnt_i">
<num>(i)</num>
<content currentId="bill_1__art_2__lst_1__pnt_i__content">
<p>â??<term currentId="bill_1__art_2__lst_1__pnt_i__p_1__term_1" refersTo="#bill_1__scientificResearchAndDevelopment">scientific research and development</term>â?? means
<def currentId="bill_1__art_2__lst_1__pnt_i__p_1__def_1" refersTo="#bill_1__scientificResearchAndDevelopment">any scientific experimentation, analysis or
research carried out under strictly controlled
conditions, in accordance with <ref currentId="bill_1__art_2__lst_1__pnt_i__p_1__def_1__ref_1" href="/eu/act/regulation/2006/1907">Regulation
(EC) No 1907/2006</ref></def>;</p>
</content>
</point>
<point currentId="bill_1__art_2__lst_1__pnt_j">
<num>(j)</num>
<content currentId="bill_1__art_2__lst_1__pnt_j__content">
<p>â??<term currentId="bill_1__art_2__lst_1__pnt_j__p_1__term_1" refersTo="#bill_1__unitedNationsSystem">United Nations
system</term>â?? means <def currentId="bill_1__art_2__lst_1__pnt_j__p_1__def_1" refersTo="#bill_1__unitedNationsSystem">the World Health
Organisation, the Commission on Narcotic Drugs and
the Economic and Social Committee acting in
accordance with their respective responsibilities as
described in <ref currentId="bill_1__art_2__lst_1__pnt_j__p_1__def_1__ref_1" href="/un/act/convention/narcotic drugs/en@1972">Article 3 of the 1961 United Nations Single
Convention on Narcotic Drugs, as amended by the
1972 Protocol</ref>, or in <ref currentId="bill_1__art_2__lst_1__pnt_j__p_1__def_1__ref_2" href="/un/act/convention/1971/psychotropic substance#art_2">Article 2 of the 1971 United Nations Convention
on Psychotropic Substances</ref></def>.</p>
</content>
</point>
</list>
</article>
</chapter>
<chapter currentId="bill_1__body__chp_II">
<num>CHAPTER II</num>
<heading currentId="bill_1__body__chp_II__heading">Free movement</heading>
<article currentId="bill_1__art_3">
<num>Article 3</num>
<heading currentId="bill_1__art_3__heading">Free movement</heading>
<content currentId="bill_1__art_3__content">
<p><term currentId="bill_1__art_3__p_1__term_1" refersTo="#bill_1__newPsychoactiveSubstance">New psychoactive
substances</term> and <term currentId="bill_1__art_3__p_1__term_2" refersTo="#bill_1__mixture">mixtures</term> shall move freely in the
Union for commercial and industrial use, as well as for <term currentId="bill_1__art_3__p_1__term_3" refersTo="#bill_1__scientificResearchAndDevelopment">scientific
research and development</term> purposes.</p>
</content>
</article>
<article currentId="bill_1__art_4">
<num>Article 4</num>
<heading currentId="bill_1__art_4__heading">Prevention of barriers to free
movement</heading>
<alinea currentId="bill_1__art_4__al_1">
<content currentId="bill_1__art_4__al_1__content">
<p>Insofar as the Union has not adopted measures to subject a
<term currentId="bill_1__art_4__al_1__p_1__term_1" refersTo="#bill_1__newPsychoactiveSubstance">new psychoactive
substance</term> to market restriction under this
Regulation, Member States may adopt technical regulations on
such new psychoactive substance in accordance with <ref currentId="bill_1__art_4__al_1__p_1__ref_1" href="/eu/act/directive/1998/34">Directive
98/34/EC</ref>.</p>
</content>
</alinea>
<alinea currentId="bill_1__art_4__al_2">
<content currentId="bill_1__art_4__al_2__content">
<p>Member States shall immediately communicate to the Commission
any such draft technical regulation on new psychoactive
substances, in accordance with Directive 98/34/EC.</p>
</content>
</alinea>
</article>
</chapter>
<chapter currentId="bill_1__body__chp_III">
<num>CHAPTER III</num>
<heading currentId="bill_1__body__chp_III__heading">Exchange and collection of
information</heading>
<article currentId="bill_1__art_5">
<num>Article 5</num>
<heading currentId="bill_1__art_5__heading">Information exchange</heading>
<alinea currentId="bill_1__art_5__al_1">
<content currentId="bill_1__art_5__al_1__content">
<p>National Focal Points within the European Information Network
on Drugs and Drug Addiction (â??Reitoxâ??) and Europol National
Units shall provide to the EMCDDA and Europol the available
information on the consumption, possible risks, manufacture,
extraction, importation, trade, distribution, trafficking,
commercial and scientific use of substances that appear to
be new psychoactive substances or mixtures.</p>
</content>
</alinea>
<alinea currentId="bill_1__art_5__al_2">
<content currentId="bill_1__art_5__al_2__content">
<p>The EMCDDA and Europol shall communicate that information
immediately to Reitox and the Europol National Units.</p>
</content>
</alinea>
</article>
<article currentId="bill_1__art_6">
<num>Article 6</num>
<heading currentId="bill_1__art_6__heading">Joint report</heading>
<paragraph currentId="bill_1__art_6__par_1">
<num>1.</num>
<content currentId="bill_1__art_6__par_1__content">
<p>Where the EMCDDA and Europol, or the Commission, consider
that the information shared on a new psychoactive substance
notified by several Member States gives rise to concerns
across the Union because of the health, social and safety
risks that the new psychoactive substance may pose, the
EMCDDA and Europol shall draw up a joint report on the new
psychoactive substance.</p>
</content>
</paragraph>
<paragraph currentId="bill_1__art_6__par_2">
<num>2.</num>
<list currentId="bill_1__art_6__par_2__lst_1">
<intro currentId="bill_1__art_6__par_2__lst_1__intro">
<p>The joint report shall contain the following
information:</p>
</intro>
<point currentId="bill_1__art_6__par_2__lst_1__pnt_a">
<num>(a)</num>
<content currentId="bill_1__art_6__par_2__lst_1__pnt_a__content">
<p>the nature of the risks that the new psychoactive
substance poses when consumed by humans and the
scale of the risk to public health, as referred to
in <ref currentId="bill_1__art_6__par_2__lst_1__pnt_a__p_1__ref_1" href="#bill_1__art_9__par_1">Article 9(1)</ref>;</p>
</content>
</point>
<point currentId="bill_1__art_6__par_2__lst_1__pnt_b">
<num>(b)</num>
<content currentId="bill_1__art_6__par_2__lst_1__pnt_b__content">
<p>the chemical and physical identity of the new
psychoactive substance, the methods and, if known,
the chemical precursors used for its manufacture or
extraction, and other new psychoactive substances
with a similar chemical structure that have
emerged;</p>
</content>
</point>
<point currentId="bill_1__art_6__par_2__lst_1__pnt_c">
<num>(c)</num>
<content currentId="bill_1__art_6__par_2__lst_1__pnt_c__content">
<p>the commercial and industrial use of the new
psychoactive substance, as well as its use for
scientific research and development purposes;</p>
</content>
</point>
<point currentId="bill_1__art_6__par_2__lst_1__pnt_d">
<num>(d)</num>
<content currentId="bill_1__art_6__par_2__lst_1__pnt_d__content">
<p>the human and veterinary medical use of the new
psychoactive substance, including as an active
substance in a medicinal product or veterinary
medicinal product;</p>
</content>
</point>
<point currentId="bill_1__art_6__par_2__lst_1__pnt_e">
<num>(e)</num>
<content currentId="bill_1__art_6__par_2__lst_1__pnt_e__content">
<p>the involvement of criminal groups in the
manufacture, distribution or trade in the new
psychoactive substance, and any use of the new
psychoactive substance in the manufacture of
narcotic drugs or psychotropic substances;</p>
</content>
</point>
<point currentId="bill_1__art_6__par_2__lst_1__pnt_f">
<num>(f)</num>
<content currentId="bill_1__art_6__par_2__lst_1__pnt_f__content">
<p>whether the new psychoactive substance is currently
under assessment, or has been under assessment, by
the United Nations system;</p>
</content>
</point>
<point currentId="bill_1__art_6__par_2__lst_1__pnt_g">
<num>(g)</num>
<content currentId="bill_1__art_6__par_2__lst_1__pnt_g__content">
<p>whether the new psychoactive substance is subject to
any restriction measures in the Member States;</p>
</content>
</point>
<point currentId="bill_1__art_6__par_2__lst_1__pnt_h">
<num>(h)</num>
<content currentId="bill_1__art_6__par_2__lst_1__pnt_h__content">
<p>any existing prevention and treatment measure in
place to address the consequences of the use of the
new psychoactive substance.</p>
</content>
</point>
</list>
</paragraph>
<paragraph currentId="bill_1__art_6__par_3">
<num>3.</num>
<content currentId="bill_1__art_6__par_3__content">
<p>The EMCDDA and Europol shall request the National Focal
Points and the Europol National Units to provide additional
information on the new psychoactive substance. They shall
provide that information within four weeks from receipt of
the request.</p>
</content>
</paragraph>
<paragraph currentId="bill_1__art_6__par_4">
<num>4.</num>
<list currentId="bill_1__art_6__par_4__lst_1">
<intro currentId="bill_1__art_6__par_4__lst_1__intro">
<p>The EMCDDA and Europol shall request the European
Medicines Agency to provide information on whether, in
the Union or in any Member State, the new psychoactive
substance is:</p>
</intro>
<point currentId="bill_1__art_6__par_4__lst_1__pnt_a">
<num>(a)</num>
<content currentId="bill_1__art_6__par_4__lst_1__pnt_a__content">
<p>an active substance in a medicinal product or a
veterinary medicinal product that has obtained a
<term currentId="bill_1__art_6__par_4__lst_1__pnt_a__p_1__term_1" refersTo="#bill_1__marketingAuthorisation">marketing
authorisation</term>;</p>
</content>
</point>
<point currentId="bill_1__art_6__par_4__lst_1__pnt_b">
<num>(b)</num>
<content currentId="bill_1__art_6__par_4__lst_1__pnt_b__content">
<p>an active substance in a medicinal product or a
veterinary medicinal product that is the subject of
an application for a <term currentId="bill_1__art_6__par_4__lst_1__pnt_b__p_1__term_1" refersTo="#bill_1__marketingAuthorisation">marketing
authorisation</term>;</p>
</content>
</point>
<point currentId="bill_1__art_6__par_4__lst_1__pnt_c">
<num>(c)</num>
<content currentId="bill_1__art_6__par_4__lst_1__pnt_c__content">
<p>an active substance in a medicinal product or a
veterinary medicinal product that has obtained a
<term currentId="bill_1__art_6__par_4__lst_1__pnt_c__p_1__term_1" refersTo="#bill_1__marketingAuthorisation">marketing
authorisation</term>, but the marketing
authorisation has been suspended by the competent
authority;</p>
</content>
</point>
<point currentId="bill_1__art_6__par_4__lst_1__pnt_d">
<num>(d)</num>
<content currentId="bill_1__art_6__par_4__lst_1__pnt_d__content">
<p>an active substance in an unauthorised medicinal
product in accordance with <ref currentId="bill_1__art_6__par_4__lst_1__pnt_d__p_1__ref_1" href="/eu/act/directive/2001/83#art_5">Article 5
of Directive 2001/83/EC</ref> or in a veterinary
medicinal product prepared extemporaneously by a
person authorised to do so under national
legislation in accordance with <ref currentId="bill_1__art_6__par_4__lst_1__pnt_d__p_1__ref_2" href="/eu/act/directive/2001/82#art_10__lst_1__pnt_c">Article 10(c) of Directive 2001/82/EC</ref>.</p>
</content>
</point>
</list>
<subparagraph currentId="bill_1__art_6__par_4__spar_1">
<content currentId="bill_1__art_6__par_4__spar_1__content">
<p>Member States shall provide the European Medicines Agency
with the above information, if so requested by it.</p>
</content>
</subparagraph>
<subparagraph currentId="bill_1__art_6__par_4__spar_2">
<content currentId="bill_1__art_6__par_4__spar_2__content">
<p>The European Medicines Agency shall provide the
information at its disposal within four weeks from
receipt of the request from the EMCDDA.</p>
</content>
</subparagraph>
</paragraph>
<paragraph currentId="bill_1__art_6__par_5">
<num>5.</num>
<subparagraph currentId="bill_1__art_6__par_5__spar_1">
<content currentId="bill_1__art_6__par_5__spar_1__content">
<p>The EMCDDA shall request the European Chemicals Agency
and the European Food Safety Authority to provide the
information and data at their disposal on the new
psychoactive substance. The EMCDDA shall respect the
conditions on use of the information, which are
communicated to the EMCDDA by the European Chemicals
Agency and the European Food Safety Authority, including
conditions on information and data security and
protection of confidential business information.</p>
</content>
</subparagraph>
<subparagraph currentId="bill_1__art_6__par_5__spar_2">
<content currentId="bill_1__art_6__par_5__spar_2__content">
<p>The European Chemicals Agency and the European Food
Safety Authority shall provide the information and data
at their disposal within four weeks from receipt of the
request.</p>
</content>
</subparagraph>
</paragraph>
<paragraph currentId="bill_1__art_6__par_6">
<num>6.</num>
<subparagraph currentId="bill_1__art_6__par_6__spar_1">
<content currentId="bill_1__art_6__par_6__spar_1__content">
<p>The EMCDDA and Europol shall submit the joint report to
the Commission within eight weeks from the request for
additional information referred to in <ref currentId="bill_1__art_6__par_6__spar_1__p_1__ref_1" href="#bill_1__art_6__par_3">paragraph 3</ref>.</p>
</content>
</subparagraph>
<subparagraph currentId="bill_1__art_6__par_6__spar_2">
<content currentId="bill_1__art_6__par_6__spar_2__content">
<p>When the EMCDDA and Europol collect information on
mixtures or on several new psychoactive substances with
similar chemical structure, they shall submit individual
joint reports to the Commission within ten weeks from
the request for additional information referred to in
<ref currentId="bill_1__art_6__par_6__spar_2__p_1__ref_1" href="#bill_1__art_6__par_3">paragraph 3</ref>.</p>
</content>
</subparagraph>
</paragraph>
</article>
</chapter>
<chapter currentId="bill_1__body__chp_IV">
<num>CHAPTER IV</num>
<heading currentId="bill_1__body__chp_IV__heading">Risk assessment</heading>
<article currentId="bill_1__art_7">
<num>Article 7</num>
<heading currentId="bill_1__art_7__heading">Risk assessment procedure and
report</heading>
<paragraph currentId="bill_1__art_7__par_1">
<num>1.</num>
<content currentId="bill_1__art_7__par_1__content">
<p>Within four weeks from the receipt of the joint report
referred to in <ref currentId="bill_1__art_7__par_1__p_1__ref_1" href="#bill_1__art_6">Article 6</ref>, the Commission may
request the EMCDDA to assess the potential risks posed by
the new psychoactive substance and to draw up a risk
assessment report. The risk assessment shall be conducted by
the Scientific Committee of the EMCDDA.</p>
</content>
</paragraph>
<paragraph currentId="bill_1__art_7__par_2">
<num>2.</num>
<content currentId="bill_1__art_7__par_2__content">
<p>The risk assessment report shall include an analysis of the
criteria and of the information referred to in <ref currentId="bill_1__art_7__par_2__p_1__ref_1" href="#bill_1__art_10__par_2">Article 10(2)</ref> to enable the
Commission to determine the level of health, social and
safety risks that the new psychoactive substance poses.</p>
</content>
</paragraph>
<paragraph currentId="bill_1__art_7__par_3">
<num>3.</num>
<content currentId="bill_1__art_7__par_3__content">
<p>The Scientific Committee of the EMCDDA shall assess the risks
during a special meeting. The Committee may be extended by
not more than five experts, representing the scientific
fields relevant for ensuring a balanced assessment of the
risks of the new psychoactive substance. The Director of the
EMCDDA shall designate them from a list of experts. The
Management Board of the EMCDDA shall approve the list of
experts every three years. The Commission, the EMCDDA,
Europol and the European Medicines Agency shall each have
the right to nominate two observers.</p>
</content>
</paragraph>
<paragraph currentId="bill_1__art_7__par_4">
<num>4.</num>
<content currentId="bill_1__art_7__par_4__content">
<p>The Scientific Committee of the EMCDDA shall carry out the
risk assessment on the basis of information on the risks of
the substance and on its uses, including commercial and
industrial uses, provided by the Member States, the
Commission, the EMCDDA, Europol, the European Medicines
Agency, the European Chemicals Agency, the European Food
Safety Authority and on the basis of any other relevant
scientific evidence. It shall take into consideration all
opinions held by its members. The EMCDDA shall support the
risk assessment and shall identify information needs,
including targeted studies or tests.</p>
</content>
</paragraph>
<paragraph currentId="bill_1__art_7__par_5">
<num>5.</num>
<content currentId="bill_1__art_7__par_5__content">
<p>The EMCDDA shall submit the risk assessment report to the
Commission within twelve weeks from the date when it
received the request from the Commission.</p>
</content>
</paragraph>
<paragraph currentId="bill_1__art_7__par_6">
<num>6.</num>
<content currentId="bill_1__art_7__par_6__content">
<p>Upon request of the EMCDDA, the Commission may extend the
period to complete the risk assessment by no more than
twelve weeks to allow for additional research and data
collection to take place. The EMCDDA shall submit such a
request to the Commission within six weeks from the launch
of the risk assessment. If within two weeks of such request
being made the Commission has not objected to such request,
the risk assessment shall be so extended.</p>
</content>
</paragraph>
</article>
<article currentId="bill_1__art_8">
<num>Article 8</num>
<heading currentId="bill_1__art_8__heading">Exclusion from risk assessment</heading>
<paragraph currentId="bill_1__art_8__par_1">
<num>1.</num>
<content currentId="bill_1__art_8__par_1__content">
<p>No risk assessment shall be carried out where the new
psychoactive substance is at an advanced stage of assessment
within the United Nations system, namely once the World
Health Organisation expert committee on drug dependence has
published its critical review together with a written
recommendation, except where there is significant
information that is new or of particular relevance for the
Union and that has not been taken into account by the United
Nations system.</p>
</content>
</paragraph>
<paragraph currentId="bill_1__art_8__par_2">
<num>2.</num>
<content currentId="bill_1__art_8__par_2__content">
<p>No risk assessment shall be carried out where the new
psychoactive substance has been assessed within the United
Nations system, but it has been decided not to schedule it
under the 1961 Single Convention on Narcotic Drugs, as
amended by the 1972 Protocol, or the 1971 Convention on
Psychotropic Substances, except where there is significant
information that is new or of particular relevance for the
Union.</p>
</content>
</paragraph>
<paragraph currentId="bill_1__art_8__par_3">
<num>3.</num>
<list currentId="bill_1__art_8__par_3__lst_1">
<intro currentId="bill_1__art_8__par_3__lst_1__intro">
<p>No risk assessment shall be carried out where the new
psychoactive substance is:</p>
</intro>
<point currentId="bill_1__art_8__par_3__lst_1__pnt_a">
<num>(a)</num>
<content currentId="bill_1__art_8__par_3__lst_1__pnt_a__content">
<p>an active substance in a medicinal product or a
veterinary medicinal product that has obtained a
<term currentId="bill_1__art_8__par_3__lst_1__pnt_a__p_1__term_1" refersTo="#bill_1__marketingAuthorisation">marketing
authorisation</term>;</p>
</content>
</point>
<point currentId="bill_1__art_8__par_3__lst_1__pnt_b">
<num>(b)</num>
<content currentId="bill_1__art_8__par_3__lst_1__pnt_b__content">
<p>an active substance in a medicinal product or a
veterinary medicinal product that is the subject of
an application for a <term currentId="bill_1__art_8__par_3__lst_1__pnt_b__p_1__term_1" refersTo="#bill_1__marketingAuthorisation">marketing
authorisation</term>;</p>
</content>
</point>
<point currentId="bill_1__art_8__par_3__lst_1__pnt_c">
<num>(c)</num>
<content currentId="bill_1__art_8__par_3__lst_1__pnt_c__content">
<p>an active substance in a medicinal product or a
veterinary medicinal product that has obtained a
<term currentId="bill_1__art_8__par_3__lst_1__pnt_c__p_1__term_1" refersTo="#bill_1__marketingAuthorisation">marketing
authorisation</term>, but the marketing
authorisation has been suspended by the competent
authority.</p>
</content>
</point>
</list>
</paragraph>
</article>
</chapter>
<chapter currentId="bill_1__body__chp_V">
<num>CHAPTER V</num>
<heading currentId="bill_1__body__chp_V__heading">Market restrictions</heading>
<article currentId="bill_1__art_9">
<num>Article 9</num>
<heading currentId="bill_1__art_9__heading">Immediate risks to public health and
temporary consumer market restriction</heading>
<paragraph currentId="bill_1__art_9__par_1">
<num>1.</num>
<list currentId="bill_1__art_9__par_1__lst_1">
<intro currentId="bill_1__art_9__par_1__lst_1__intro">
<p>Where it requests a risk assessment of a new psychoactive
substance pursuant to <ref currentId="bill_1__art_9__par_1__lst_1__intro__p_1__ref_1" href="#bill_1__art_7__par_1">Article 7(1)</ref>, the
Commission shall, by means of a Decision, prohibit the
<term currentId="bill_1__art_9__par_1__lst_1__intro__p_1__term_1" refersTo="#bill_1__makingAvailableOnTheMarket">making
available on the market</term> to consumers of the
new psychoactive substance if, based on existing
information, it poses immediate risks to public health,
evidenced by:</p>
</intro>
<point currentId="bill_1__art_9__par_1__lst_1__pnt_a">
<num>(a)</num>
<content currentId="bill_1__art_9__par_1__lst_1__pnt_a__content">
<p>reported fatalities and severe health consequences
associated with the consumption of the new
psychoactive substance in several Member States,
related to the serious acute toxicity of the new
psychoactive substance;</p>
</content>
</point>
<point currentId="bill_1__art_9__par_1__lst_1__pnt_b">
<num>(b)</num>
<content currentId="bill_1__art_9__par_1__lst_1__pnt_b__content">
<p>the prevalence and patterns of use of the new
psychoactive substance in the general population and
in specific groups, in particular frequency,
quantities and modality of use, its availability to
consumers and the potential for diffusion, which
indicate that the scale of the risk is
considerable.</p>
</content>
</point>
</list>
</paragraph>
<paragraph currentId="bill_1__art_9__par_2">
<num>2.</num>
<subparagraph currentId="bill_1__art_9__par_2__spar_1">
<content currentId="bill_1__art_9__par_2__spar_1__content">
<p>The Commission shall adopt the Decision referred to in
<ref currentId="bill_1__art_9__par_2__spar_1__p_1__ref_1" href="#bill_1__art_9__par_1">paragraph 1</ref> by means of
implementing acts. Those implementing acts shall be
adopted in accordance with the examination procedure
referred to in <ref currentId="bill_1__art_9__par_2__spar_1__p_1__ref_2" href="#bill_1__art_19__par_2">Article 19(2)</ref>.</p>
</content>
</subparagraph>
<subparagraph currentId="bill_1__art_9__par_2__spar_2">
<content currentId="bill_1__art_9__par_2__spar_2__content">
<p>On duly justified imperative grounds of urgency relating
to a rapid increase in the number of reported fatalities
in several Member States associated with the consumption
of the new psychoactive substance concerned, the
Commission shall adopt immediately applicable
implementing acts in accordance with the procedure laid
down in <ref currentId="bill_1__art_9__par_2__spar_2__p_1__ref_1" href="#bill_1__art_19__par_3">Article 19(3)</ref>.</p>
</content>
</subparagraph>
</paragraph>
<paragraph currentId="bill_1__art_9__par_3">
<num>3.</num>
<content currentId="bill_1__art_9__par_3__content">
<p>The market restriction contained in the Decision referred to
in <ref currentId="bill_1__art_9__par_3__p_1__ref_1" href="#bill_1__art_9__par_1">paragraph 1</ref> shall not exceed
a period of twelve months.</p>
</content>
</paragraph>
</article>
<article currentId="bill_1__art_10">
<num>Article 10</num>
<heading currentId="bill_1__art_10__heading">Determination of the level of health,
social and safety risks following the risk assessment</heading>
<paragraph currentId="bill_1__art_10__par_1">
<num>1.</num>
<content currentId="bill_1__art_10__par_1__content">
<p>The Commission shall determine the level of the health,
social and safety risks posed by the new psychoactive
substance on which a risk assessment report was drafted. It
shall do so on the basis of all available evidence, in
particular the risk assessment report.</p>
</content>
</paragraph>
<paragraph currentId="bill_1__art_10__par_2">
<num>2.</num>
<list currentId="bill_1__art_10__par_2__lst_1">
<intro currentId="bill_1__art_10__par_2__lst_1__intro">
<p>The Commission shall take the following criteria into
account when determining the level of risk of a new
psychoactive substance:</p>
</intro>
<point currentId="bill_1__art_10__par_2__lst_1__pnt_a">
<num>(a)</num>
<content currentId="bill_1__art_10__par_2__lst_1__pnt_a__content">
<p>the harm to health caused by the consumption of the
new psychoactive substance associated with its acute
and chronic toxicity, abuse liability and
dependence-producing potential, in particular
injury, disease, and physical and mental
impairment;</p>
</content>
</point>
<point currentId="bill_1__art_10__par_2__lst_1__pnt_b">
<num>(b)</num>
<content currentId="bill_1__art_10__par_2__lst_1__pnt_b__content">
<p>the social harm caused to individuals and to society,
in particular its impact on social functioning,
public order and criminal activities, organised
crime activity associated with the new psychoactive
substance, illicit profits generated by the
production, trade and distribution of the new
psychoactive substance, and associated economic
costs of the social harm;</p>
</content>
</point>
<point currentId="bill_1__art_10__par_2__lst_1__pnt_c">
<num>(c)</num>
<content currentId="bill_1__art_10__par_2__lst_1__pnt_c__content">
<p>the risks to safety, in particular the spread of
diseases, including transmission of blood borne
viruses, the consequences of physical and mental
impairment on the ability to drive, the impact of
the manufacture, transport and disposal of the new
psychoactive substance and associated waste
materials on the environment.</p>
</content>
</point>
</list>
<subparagraph currentId="bill_1__art_10__par_2__spar_1">
<content currentId="bill_1__art_10__par_2__spar_1__content">
<p>The Commission shall also take into account the
prevalence and patterns of use of the new psychoactive
substance in the general population and in specific
groups, its availability to consumers, its potential for
diffusion, the number of Member States where it poses
health, social and safety risks, the extent of its
commercial and industrial use, and its use for
scientific research and development purposes.</p>
</content>
</subparagraph>
</paragraph>
</article>
<article currentId="bill_1__art_11">
<num>Article 11</num>
<heading currentId="bill_1__art_11__heading">Low risks</heading>
<list currentId="bill_1__art_11__lst_1">
<intro currentId="bill_1__art_11__lst_1__intro">
<p>The Commission shall not adopt restriction measures on a new
psychoactive substance if, based on existing evidence, it
poses, overall, low health, social and safety risks, in
particular:</p>
</intro>
<point currentId="bill_1__art_11__lst_1__pnt_a">
<num>(a)</num>
<content currentId="bill_1__art_11__lst_1__pnt_a__content">
<p>the harm to health caused by the consumption of the new
psychoactive substance associated with its acute and
chronic toxicity, abuse liability and
dependence-producing potential, is limited, as it
provokes minor injury and disease, and minor physical or
mental impairment;</p>
</content>
</point>
<point currentId="bill_1__art_11__lst_1__pnt_b">
<num>(b)</num>
<content currentId="bill_1__art_11__lst_1__pnt_b__content">
<p>the social harm caused to individuals and to society is
limited, in particular regarding its impact on social
functioning and public order, criminal activities
associated with the new psychoactive substance is low,
illicit profits generated by the production, trade and
distribution of the new psychoactive substance and
associated economic costs are non-existent or
negligible;</p>
</content>
</point>
<point currentId="bill_1__art_11__lst_1__pnt_c">
<num>(c)</num>
<content currentId="bill_1__art_11__lst_1__pnt_c__content">
<p>the risks to safety are limited, in particular low risk
of spread of diseases, including transmission of blood
borne viruses, non-existent or low consequences of
physical and mental impairment on the ability to drive,
and the impact of the manufacture, transport and
disposal of the new psychoactive substance and
associated waste materials on the environment is
low.</p>
</content>
</point>
</list>
</article>
<article currentId="bill_1__art_12">
<num>Article 12</num>
<heading currentId="bill_1__art_12__heading">Moderate risks and permanent consumer
market restriction</heading>
<paragraph currentId="bill_1__art_12__par_1">
<num>1.</num>
<list currentId="bill_1__art_12__par_1__lst_1">
<intro currentId="bill_1__art_12__par_1__lst_1__intro">
<p>The Commission shall, by means of a Decision, without
undue delay, prohibit the making available on the market
to consumers of the new psychoactive substance if, based
on existing evidence, it poses, overall, moderate
health, social and safety risks, in particular:</p>
</intro>
<point currentId="bill_1__art_12__par_1__lst_1__pnt_a">
<num>(a)</num>
<content currentId="bill_1__art_12__par_1__lst_1__pnt_a__content">
<p>the harm to health caused by the consumption of the
new psychoactive substance associated with its acute
and chronic toxicity, abuse liability and
dependence-producing potential, is moderate, as it
generally provokes non-lethal injury and disease,
and moderate physical or mental impairment;</p>
</content>
</point>
<point currentId="bill_1__art_12__par_1__lst_1__pnt_b">
<num>(b)</num>
<content currentId="bill_1__art_12__par_1__lst_1__pnt_b__content">
<p>the social harm caused to individuals and to society
is moderate, in particular regarding its impact on
social functioning and public order, producing
public nuisance; criminal activities and organised
crime activity associated with the substance are
sporadic, illicit profits and economic costs are
moderate;</p>
</content>
</point>
<point currentId="bill_1__art_12__par_1__lst_1__pnt_c">
<num>(c)</num>
<content currentId="bill_1__art_12__par_1__lst_1__pnt_c__content">
<p>the risks to safety are moderate, in particular
sporadic spread of diseases, including transmission
of blood borne viruses, moderate consequences of
physical and mental impairment on the ability to
drive, and the manufacture, transport and disposal
of the new psychoactive substance and associated
waste materials results in environmental
nuisance.</p>
</content>
</point>
</list>
</paragraph>
<paragraph currentId="bill_1__art_12__par_2">
<num>2.</num>
<content currentId="bill_1__art_12__par_2__content">
<p>The Commission shall adopt the Decision referred to in
paragraph 1 by means of implementing acts. Those
implementing acts shall be adopted in accordance with the
examination procedure referred to in <ref currentId="bill_1__art_12__par_2__p_1__ref_1" href="#bill_1__art_19__par_2">Article 19(2)</ref>.</p>
</content>
</paragraph>
</article>
<article currentId="bill_1__art_13">
<num>Article 13</num>
<heading currentId="bill_1__art_13__heading">Severe risks and permanent market
restriction</heading>
<paragraph currentId="bill_1__art_13__par_1">
<num>1.</num>
<list currentId="bill_1__art_13__par_1__lst_1">
<intro currentId="bill_1__art_13__par_1__lst_1__intro">
<p>The Commission shall, by means of a Decision, without
undue delay, prohibit the production, manufacture,
making available on the market including importation to
the Union, transport, and exportation from the Union of
the new psychoactive substance if, based on existing
evidence, it poses, overall, severe health, social and
safety risks, in particular:</p>
</intro>
<point currentId="bill_1__art_13__par_1__lst_1__pnt_a">
<num>(a)</num>
<content currentId="bill_1__art_13__par_1__lst_1__pnt_a__content">
<p>the harm to health caused by the consumption of the
new psychoactive substance associated with its acute
and chronic toxicity, abuse liability and
dependence-producing potential, is life threatening,
as it generally provokes death or lethal injury,
severe disease, and severe physical or mental
impairment;</p>
</content>
</point>
<point currentId="bill_1__art_13__par_1__lst_1__pnt_b">
<num>(b)</num>
<content currentId="bill_1__art_13__par_1__lst_1__pnt_b__content">
<p>the social harm caused to individuals and to society
is severe, in particular regarding its impact on
social functioning and public order, resulting in
public order disruption, violent and anti-social
behaviour causing damage to the user, to others and
to property; criminal activities and organised crime
activity associated with the new psychoactive
substance are systematic, illicit profits, and
economic costs are high;</p>
</content>
</point>
<point currentId="bill_1__art_13__par_1__lst_1__pnt_c">
<num>(c)</num>
<content currentId="bill_1__art_13__par_1__lst_1__pnt_c__content">
<p>the risks to safety are severe, in particular
significant spread of diseases, including
transmission of blood borne viruses, severe
consequences of physical and mental impairment on
the ability to drive, and the manufacture, transport
and disposal of the new psychoactive substance and
associated waste materials result in environmental
harm.</p>
</content>
</point>
</list>
</paragraph>
<paragraph currentId="bill_1__art_13__par_2">
<num>2.</num>
<content currentId="bill_1__art_13__par_2__content">
<p>The Commission shall adopt the Decision referred to in <ref currentId="bill_1__art_13__par_2__p_1__ref_1" href="#bill_1__art_13__par_1">paragraph 1</ref> by means of
implementing acts. Those implementing acts shall be adopted
in accordance with the examination procedure referred to in
<ref currentId="bill_1__art_13__par_2__p_1__ref_2" href="#bill_1__art_19__par_2">Article 19(2)</ref>.</p>
</content>
</paragraph>
</article>
<article currentId="bill_1__art_14">
<num>Article 14</num>
<heading currentId="bill_1__art_14__heading">Authorised uses</heading>
<paragraph currentId="bill_1__art_14__par_1">
<num>1.</num>
<content currentId="bill_1__art_14__par_1__content">
<p>The Decisions referred to in <ref currentId="bill_1__art_14__par_1__p_1__ref_1" href="#bill_1__art_9__par_1">Article 9(1)</ref> and <ref currentId="bill_1__art_14__par_1__p_1__ref_2" href="#bill_1__art_12__par_1">Article 12(1)</ref> shall not
impede the free movement in the Union and the making
available on the market to consumers of new psychoactive
substances that are active substances in medicinal products
or veterinary medicinal products that have obtained a <term currentId="bill_1__art_14__par_1__p_1__term_1" refersTo="#bill_1__marketingAuthorisation">marketing
authorisation</term>.</p>
</content>
</paragraph>
<paragraph currentId="bill_1__art_14__par_2">
<num>2.</num>
<list currentId="bill_1__art_14__par_2__lst_1">
<intro currentId="bill_1__art_14__par_2__lst_1__intro">
<p>The Decisions referred to in <ref currentId="bill_1__art_14__par_2__lst_1__intro__p_1__ref_1" href="#bill_1__art_13__par_1">Article 13(1)</ref> shall not
impede the free movement in the Union and the
production, manufacture, making available on the market
including importation to the Union, transport, and
exportation from the Union of new psychoactive
substances:</p>
</intro>
<point currentId="bill_1__art_14__par_2__lst_1__pnt_a">
<num>(a)</num>
<content currentId="bill_1__art_14__par_2__lst_1__pnt_a__content">
<p>for scientific research and development purposes;</p>
</content>
</point>
<point currentId="bill_1__art_14__par_2__lst_1__pnt_b">
<num>(b)</num>
<content currentId="bill_1__art_14__par_2__lst_1__pnt_b__content">
<p>for uses authorised under Union legislation;</p>
</content>
</point>
<point currentId="bill_1__art_14__par_2__lst_1__pnt_c">
<num>(c)</num>
<content currentId="bill_1__art_14__par_2__lst_1__pnt_c__content">
<p>that are active substances in medicinal products or
veterinary medicinal products that have obtained a
marketing authorisation;</p>
</content>
</point>
<point currentId="bill_1__art_14__par_2__lst_1__pnt_d">
<num>(d)</num>
<content currentId="bill_1__art_14__par_2__lst_1__pnt_d__content">
<p>for use in the manufacture of substances and products
provided that the new psychoactive substances are
transformed in such a condition that they cannot be
abused or recovered.</p>
</content>
</point>
</list>
</paragraph>
<paragraph currentId="bill_1__art_14__par_3">
<num>3.</num>
<content currentId="bill_1__art_14__par_3__content">
<p>The Decisions referred to in <ref currentId="bill_1__art_14__par_3__p_1__ref_1" href="#bill_1__art_13__par_1">Article 13(1)</ref> may set
requirements and conditions for the production, manufacture,
making available on the market including importation to the
Union, transport, and exportation from the Union of new
psychoactive substances posing severe health, social and
safety risks for the uses listed in <ref currentId="bill_1__art_14__par_3__p_1__ref_2" href="#bill_1__art_14__par_2">paragraph 2</ref>.</p>
</content>
</paragraph>
</article>
</chapter>
<chapter currentId="bill_1__body__chp_VI">
<num>CHAPTER VI</num>
<heading currentId="bill_1__body__chp_VI__heading">Monitoring and re-examination</heading>
<article currentId="bill_1__art_15">
<num>Article 15</num>
<heading currentId="bill_1__art_15__heading">Monitoring</heading>
<content currentId="bill_1__art_15__content">
<p>The EMCDDA and Europol, with the support of Reitox, shall monitor
all new psychoactive substances on which a joint report has been
drawn up.</p>
</content>
</article>
<article currentId="bill_1__art_16">
<num>Article 16</num>
<heading currentId="bill_1__art_16__heading">Re-examination of level of
risks</heading>
<content currentId="bill_1__art_16__content">
<p>Where new information and evidence is available on the risks
posed by a new psychoactive substance the health, social and
safety risks of which have already been determined in accordance
with <ref currentId="bill_1__art_16__p_1__ref_1" href="#bill_1__art_10">Article
10</ref>, the Commission shall request the EMCDDA to update
the risk assessment report drafted on the new psychoactive
substance and shall re-examine the level of risks that the new
psychoactive substance poses.</p>
</content>
</article>
</chapter>
<chapter currentId="bill_1__body__chp_VII">
<num>CHAPTER VII</num>
<heading currentId="bill_1__body__chp_VII__heading">Sanctions and remedy</heading>
<article currentId="bill_1__art_17">
<num>Article 17</num>
<heading currentId="bill_1__art_17__heading">Sanctions</heading>
<content currentId="bill_1__art_17__content">
<p>Member States shall lay down the rules on sanctions applicable to
infringements of the Decisions referred to in <ref currentId="bill_1__art_17__p_1__ref_1" href="#bill_1__art_9__par_1">Article
9(1)</ref>, <ref currentId="bill_1__art_17__p_1__ref_2" href="#bill_1__art_12__par_1">Article 12(1)</ref> and <ref currentId="bill_1__art_17__p_1__ref_3" href="#bill_1__art_13__par_1">Article
13(1)</ref> and shall take all necessary measures to ensure
that they are implemented. The sanctions provided for shall be
effective, proportionate and dissuasive. Member States shall
notify those rules on sanctions and any subsequent amendment
affecting those provisions to the Commission without delay.</p>
</content>
</article>
<article currentId="bill_1__art_18">
<num>Article 18</num>
<heading currentId="bill_1__art_18__heading">Remedy</heading>
<content currentId="bill_1__art_18__content">
<p>Any person whose rights are affected by the implementation of a
sanction taken by a Member State in accordance with <ref currentId="bill_1__art_18__p_1__ref_1" href="#bill_1__art_17">Article
17</ref> shall have the right to an effective remedy before
a tribunal in that Member State.</p>
</content>
</article>
</chapter>
<chapter currentId="bill_1__body__chp_VIII">
<num>CHAPTER VIII</num>
<heading currentId="bill_1__body__chp_VIII__heading">PROCEDURES</heading>
<article currentId="bill_1__art_19">
<num>Article 19</num>
<heading currentId="bill_1__art_19__heading">Committee</heading>
<paragraph currentId="bill_1__art_19__par_1">
<num>1.</num>
<content currentId="bill_1__art_19__par_1__content">
<p>The Commission shall be assisted by a committee. That
committee shall be a committee within the meaning of <ref currentId="bill_1__art_19__par_1__p_1__ref_1" href="/eu/act/regulation/2011/182">Regulation (EU) No
182/2011</ref>.</p>
</content>
</paragraph>
<paragraph currentId="bill_1__art_19__par_2">
<num>2.</num>
<content currentId="bill_1__art_19__par_2__content">
<p>Where reference is made to this paragraph, <ref currentId="bill_1__art_19__par_2__p_1__ref_1" href="/eu/act/regulation/2011/182#art_5">Article 5 of
Regulation (EU) No 182/2011</ref> shall apply.</p>
</content>
</paragraph>
<paragraph currentId="bill_1__art_19__par_3">
<num>3.</num>
<content currentId="bill_1__art_19__par_3__content">
<p>Where reference is made to this paragraph, <ref currentId="bill_1__art_19__par_3__p_1__ref_1" href="/eu/act/regulation/2011/182#art_8">Article 8 of
Regulation (EU) No 182/2011</ref>, in conjunction with
<ref currentId="bill_1__art_19__par_3__p_1__ref_2" href="/eu/act/regulation/2011/182#art_5">Article 5
thereof</ref>, shall apply.</p>
</content>
</paragraph>
</article>
</chapter>
<chapter currentId="bill_1__body__chp_IX">
<num>CHAPTER IX</num>
<heading currentId="bill_1__body__chp_IX__heading">Final Provisions</heading>
<article currentId="bill_1__art_20">
<num>Article 20</num>
<heading currentId="bill_1__art_20__heading">Research and analysis</heading>
<content currentId="bill_1__art_20__content">
<p>The Commission and the Member States shall support the
development, sharing and dissemination of information and
knowledge on new psychoactive substances. They shall do so by
facilitating cooperation between the EMCDDA, other Union
agencies, and scientific and research centres.</p>
</content>
</article>
<article currentId="bill_1__art_21">
<num>Article 21</num>
<heading currentId="bill_1__art_21__heading">Reporting</heading>
<content currentId="bill_1__art_21__content">
<p>The EMCDDA and Europol shall report annually on the
implementation of this Regulation.</p>
</content>
</article>
<article currentId="bill_1__art_22">
<num>Article 22</num>
<heading currentId="bill_1__art_22__heading">Evaluation</heading>
<content currentId="bill_1__art_22__content">
<p>By <placeholder currentId="bill_1__art_22__p_1__placeholder_1">[five years after the entry into force of this
Regulation]</placeholder> at the latest and every five years
thereafter, the Commission shall assess the implementation,
application and effectiveness of this Regulation and publish a
report.</p>
</content>
</article>
<article currentId="bill_1__art_23">
<num>Article 23</num>
<heading currentId="bill_1__art_23__heading">Replacement of Decision
2005/387/JHA</heading>
<content currentId="bill_1__art_23__content">
<p><ref currentId="bill_1__art_23__p_1__ref_1" href="/eu/act/decision/2005/387/JHA">Decision
2005/387/JHA</ref> is hereby repealed and replaced, without
prejudice to the obligations of the Member States relating to
the time limit for transposition of that Decision into national
law. References to <ref currentId="bill_1__art_23__p_1__ref_2" href="/eu/act/decision/2005/387/JHA">Decision
2005/387/JHA</ref> shall be construed as reference to this
Regulation.</p>
</content>
</article>
<article currentId="bill_1__art_24">
<num>Article 24</num>
<heading currentId="bill_1__art_24__heading">Entry into force</heading>
<alinea currentId="bill_1__art_24__al_1">
<content currentId="bill_1__art_24__al_1__content">
<p>This Regulation shall enter into force on the
<placeholder currentId="bill_1__art_24__al_1__p_1__placeholder_1">[twentieth]</placeholder> day following
that of its publication in the Official Journal of the
European Union.</p>
</content>
</alinea>
<alinea currentId="bill_1__art_24__al_2">
<content currentId="bill_1__art_24__al_2__content">
<p>This Regulation shall be binding in its entirety and directly
applicable in all Member States.</p>
</content>
</alinea>
</article>
</chapter>
</body>
<conclusions currentId="bill_1__component_2__conclusions">
<p>Done at Brussels,</p>
<container currentId="bill_1__component_2__conclusions__container_1" name="signature">
<p currentId="bill_1__component_2__conclusions__container_1__p_1">For the European Parliament</p>
<p currentId="bill_1__component_2__conclusions__container_1__p_2">The President</p>
</container>
<container currentId="bill_1__component_2__conclusions__container_2" name="signature">
<p currentId="bill_1__component_2__conclusions__container_2__p_1">For the Council</p>
<p currentId="bill_1__component_2__conclusions__container_2__p_2">The President</p>
</container>
</conclusions>
</bill>
</component>
<component currentId="component_3">
<doc name="financialStatement" contains="originalVersion">
<meta>
<identification source="http://www.europarl.europa.eu/";>
<FRBRWork>
<FRBRthis currentId="doc_2__component_3__FRBRWork__FRBRthis" value="/eu/documentCollection/COMproposal/COM/2013-09-17/619/financialStatement/main"/>
<FRBRuri currentId="doc_2__component_3__FRBRWork__FRBRuri" value="/eu/documentCollection/COMproposal/COM/2013-09-17/619/financialStatement/"/>
<FRBRdate currentId="doc_2__component_3__FRBRWork__FRBRdate_1" date="2012-01-01" name="instantiation"/>
<FRBRauthor currentId="doc_2__component_3__FRBRWork__FRBRauthor_1" href="eu.europa.europarl.codict:institution/id=10" as="xml4ep:/role/document/author"/>
<FRBRcountry currentId="doc_2__component_3__FRBRWork__FRBRcountry" value="eu"/>
<FRBRprescriptive currentId="doc_2__component_3__FRBRWork__FRBRprescriptive" value="false"/>
<FRBRauthoritative currentId="doc_2__component_3__FRBRWork__FRBRauthoritative" value="false"/>
</FRBRWork>
<FRBRExpression>
<FRBRthis currentId="doc_2__component_3__FRBRExpression__FRBRthis" value="/eu/documentCollection/COMproposal/COM/2013-09-17/619/financialStatement/en@/main"/>
<FRBRuri currentId="doc_2__component_3__FRBRExpression__FRBRuri" value="/eu/documentCollection/COMproposal/COM/2013-09-17/619/financialStatement/en@"/>
<FRBRdate currentId="doc_2__component_3__FRBRExpression__FRBRdate_1" date="2012-01-01" name="instantiation"/>
<FRBRauthor currentId="doc_2__component_3__FRBRExpression__FRBRauthor_1" href="eu.europa.europarl.codict:institution/id=10"/>
<FRBRlanguage currentId="doc_2__component_3__FRBRExpression__FRBRlanguage_1" language="en"/>
</FRBRExpression>
<FRBRManifestation>
<FRBRthis currentId="doc_2__component_3__FRBRManifestation__FRBRthis" value="/eu/documentCollection/COMproposal/COM/2013-09-17/619/financialStatement/en@/main.xml"/>
<FRBRuri currentId="doc_2__component_3__FRBRManifestation__FRBRuri" value="/eu/documentCollection/COMproposal/COM/2013-09-17/619/financialStatement/en@.ako"/>
<FRBRdate currentId="doc_2__component_3__FRBRManifestation__FRBRdate_1" date="2012-01-01" name="instantiation"/>
<FRBRauthor currentId="doc_2__component_3__FRBRManifestation__FRBRauthor_1" href="#parisse" as="#poc"/>
</FRBRManifestation>
</identification>
</meta>
<preface currentId="doc_2__preface">
<longTitle currentId="doc_2__preface__ltti_1">
<p>LEGISLATIVE FINANCIAL STATEMENT</p>
</longTitle>
</preface>
<mainBody currentId="doc_2__component_3__mainBody">
<tblock currentId="doc_2__tblock_1">
<num>1.</num>
<heading currentId="doc_2__tblock_1__heading">FRAMEWORK OF THE
PROPOSAL/INITIATIVE</heading>
<tblock currentId="doc_2__tblock_1.1">
<num>1.1.</num>
<heading currentId="doc_2__tblock_1.1__heading">Title of the
proposal/initiative</heading>
<p>Regulation of the European Parliament and of the Council on new
psychoactive substances</p>
</tblock>
<tblock currentId="doc_2__tblock_1.2">
<num>1.2.</num>
<heading currentId="doc_2__tblock_1.2__heading">Policy area(s) concerned in the
ABM/ABB structure<authorialNote currentId="doc_2__authorialNote_25" marker="25" placement="bottom">
<p><abbr currentId="doc_2__authorialNote_25__p_1__abbr_1">ABM</abbr>: <def currentId="doc_2__authorialNote_25__p_1__def_1">activity-based management</def> â??
<abbr currentId="doc_2__authorialNote_25__p_1__abbr_2">ABB</abbr>: <def currentId="doc_2__authorialNote_25__p_1__def_2">activity-based
budgeting</def>.</p>
</authorialNote></heading>
<p>Title 33: Justice</p>
</tblock>
<tblock currentId="doc_2__tblock_1.3">
<num>1.3.</num>
<heading currentId="doc_2__tblock_1.3__heading">Nature of the
proposal/initiative</heading>
<p currentId="doc_2__tblock_1.3__p_1">â? The proposal/initiative relates to <b currentId="doc_2__tblock_1.3__p_1__b_1">a new action</b></p>
<p currentId="doc_2__tblock_1.3__p_2">â?¡ The proposal/initiative relates to <b currentId="doc_2__tblock_1.3__p_2__b_1">a new action following a
pilot project/preparatory action</b><authorialNote currentId="doc_2__authorialNote_26" marker="26" placement="bottom">
<p>As referred to in Article 54(2)(a) or (b) of the Financial
Regulation.</p>
</authorialNote></p>
<p currentId="doc_2__tblock_1.3__p_3">â?¡ The proposal/initiative relates to <b currentId="doc_2__tblock_1.3__p_3__b_1">the extension of an existing
action</b></p>
<p currentId="doc_2__tblock_1.3__p_4">â?¡ The proposal/initiative relates to <b currentId="doc_2__tblock_1.3__p_4__b_1">an action redirected towards
a new action</b></p>
</tblock>
<tblock currentId="doc_2__tblock_1.4">
<num>1.4.</num>
<heading currentId="doc_2__tblock_1.4__heading">Objective(s)</heading>
<tblock currentId="doc_2__tblock_1.4.1">
<num>1.4.1.</num>
<heading currentId="doc_2__tblock_1.4.1__heading">The Commission's
multiannual strategic objective(s) targeted by the
proposal/initiative</heading>
<p>Building a safe and secure Europe: to improve the capacity to
detect, assess and respond rapidly and effectively to the
emergence of new psychoactive substances</p>
</tblock>
<tblock currentId="doc_2__tblock_1.4.2">
<num>1.4.2.</num>
<heading currentId="doc_2__tblock_1.4.2__heading">Specific
objective(s) and ABM/ABB activity(ies) concerned</heading>
<table currentId="doc_2__tblock_1.4.2__tbl_1">
<tr currentId="doc_2__tblock_1.4.2__tbl_1__tr_1">
<td currentId="doc_2__tblock_1.4.2__tbl_1__tr_1__td_1" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_1.4.2__tbl_1__tr_1__td_1__p_1"><u currentId="doc_2__tblock_1.4.2__tbl_1__tr_1__td_1__p_1__u_1">Specific objective No:</u></p>
<p currentId="doc_2__tblock_1.4.2__tbl_1__tr_1__td_1__p_2">Prevent and reduce drug use, drug dependence and
drug-related harm</p>
<p currentId="doc_2__tblock_1.4.2__tbl_1__tr_1__td_1__p_3"><u currentId="doc_2__tblock_1.4.2__tbl_1__tr_1__td_1__p_3__u_1">ABM/ABB activity(ies) concerned</u></p>
</td>
</tr>
</table>
</tblock>
<tblock currentId="doc_2__tblock_1.4.3">
<num>1.4.3.</num>
<heading currentId="doc_2__tblock_1.4.3__heading">Expected result(s)
and impact</heading>
<p>To reduce the availability in the EU internal market of new
psychoactive substances that pose health, social and safety
risks, and to prevent the emergence of obstacles to legitimate
trade and increase legal certainty for economic operators.</p>
</tblock>
<tblock currentId="doc_2__tblock_1.4.4">
<num>1.4.4.</num>
<heading currentId="doc_2__tblock_1.4.4__heading">Indicators of
results and impact</heading>
<blockList currentId="doc_2__tblock_1.4.4__lst_1">
<item currentId="doc_2__tblock_1.4.4__lst_1__item_1">
<p currentId="doc_2__tblock_1.4.4__lst_1__item_1__p_1">· Number of new psychoactive substances notified, of
Member States that notified it.</p>
<p currentId="doc_2__tblock_1.4.4__lst_1__item_1__p_2">· Known commercial and industrial uses of new
psychoactive substances.</p>
</item>
<item currentId="doc_2__tblock_1.4.4__lst_1__item_2">
<p>· Characteristics and availability (including on the
internet) of the substances.</p>
</item>
<item currentId="doc_2__tblock_1.4.4__lst_1__item_3">
<p>· Number of joint reports and risk assessments
conducted.</p>
</item>
<item currentId="doc_2__tblock_1.4.4__lst_1__item_4">
<p>· Number and type of restriction measures on new
psychoactive substances at the EU and national
level.</p>
</item>
<item currentId="doc_2__tblock_1.4.4__lst_1__item_5">
<p>· Number of health alerts issued on new psychoactive
substances and follow-up given by responsible
authorities.</p>
</item>
</blockList>
</tblock>
</tblock>
<tblock currentId="doc_2__tblock_1.5">
<num>1.5.</num>
<heading currentId="doc_2__tblock_1.5__heading">Grounds for the
proposal/initiative</heading>
<tblock currentId="doc_2__tblock_1.5.1">
<num>1.5.1.</num>
<heading currentId="doc_2__tblock_1.5.1__heading">Requirement(s) to
be met in the short or long term</heading>
<blockList currentId="doc_2__tblock_1.5.1__lst_1">
<item currentId="doc_2__tblock_1.5.1__lst_1__item_1">
<num>·</num>
<p>To reduce obstacles to legitimate trade in new
psychoactive substances and prevent the emergence of
such obstacles.</p>
</item>
<item currentId="doc_2__tblock_1.5.1__lst_1__item_2">
<num>·</num>
<p>To protect the health and safety of consumers from the
risks posed by harmful new psychoactive substances.</p>
</item>
<item currentId="doc_2__tblock_1.5.1__lst_1__item_3">
<num>·</num>
<p>To address substances that pose health, social and safety
risks, and that raise immediate public health
concerns.</p>
</item>
<item currentId="doc_2__tblock_1.5.1__lst_1__item_4">
<num>·</num>
<p>To improve the capacity to rapidly identify and assess
new psychoactive substances, and to address them
depending on their risks.</p>
</item>
<item currentId="doc_2__tblock_1.5.1__lst_1__item_5">
<num>·</num>
<p>To facilitate legitimate trade in such substances within
the internal market.</p>
</item>
<item currentId="doc_2__tblock_1.5.1__lst_1__item_6">
<num>·</num>
<p>To improve consistency between national responses to
harmful new psychoactive substances which raise
cross-border concerns and to reduce the risk of their
displacement between the Member States.</p>
</item>
</blockList>
</tblock>
<tblock currentId="doc_2__tblock_1.5.2">
<num>1.5.2.</num>
<heading currentId="doc_2__tblock_1.5.2__heading">Added value of EU
involvement</heading>
<p>EU action on new psychoactive substances would boost the exchange
of information among the Member States, with the clear added
value of alerting Member States to potentially harmful
substances that have emerged in other Member States, to help
them anticipate a potential public health threat. The assessment
of risks of substances at the EU level has the added value of
pooling scientific resources and analytical capacities from
across the EU, to provide the best evidence available on a
substance and help develop effective responses to it. EU-level
decisions on restricting the availability of harmful substances
would increase legal certainty and reduce obstacles for economic
operators in the market for legitimate uses, while improving
consumer protection across the EU.</p>
</tblock>
<tblock currentId="doc_2__tblock_1.5.3">
<num>1.5.3.</num>
<heading currentId="doc_2__tblock_1.5.3__heading">Lessons learned
from similar experiences in the past</heading>
<blockList currentId="doc_2__tblock_1.5.3__lst_1">
<listIntroduction currentId="doc_2__tblock_1.5.3__lst_1__intro">The 2011 Commission's
assessment report<authorialNote currentId="doc_2__authorialNote_27" marker="27" placement="bottom">
<p><ref currentId="doc_2__authorialNote_27__p_1__ref_1" href="/eu/bill/COMproposal/2011/430">COM(2011) 430
final</ref> and SEC(2011) 912.</p>
</authorialNote> on the implementing of the current Council
Decision 2005/387/JHA on the information exchange,
risk-assessment and control of new psychoactive substances,
based on an extensive consultation of Member State
stakeholders, concluded that the Council Decision is a
useful instrument for tackling new substances at the EU
level, but that it has several major shortcomings,
including:</listIntroduction>
<item currentId="doc_2__tblock_1.5.3__lst_1__item_1">
<num>(1)</num>
<p>It is slow and reactive, and it is therefore not able to
address effectively the increase in the number of new
psychoactive substances.</p>
</item>
<item currentId="doc_2__tblock_1.5.3__lst_1__item_2">
<num>(2)</num>
<p>Insufficient evidence is available to take appropriate
and sustainable decisions under this instrument.</p>
</item>
<item currentId="doc_2__tblock_1.5.3__lst_1__item_3">
<num>(3)</num>
<p>It lacks options for restriction measures.</p>
</item>
</blockList>
</tblock>
<tblock currentId="doc_2__tblock_1.5.4">
<num>1.5.4.</num>
<heading currentId="doc_2__tblock_1.5.4__heading">Compatibility and
possible synergy with other appropriate instruments</heading>
<p>Action in the field of new psychoactive substances is in
compliance with the existing rules on the functioning of the
internal market, as well as with EU strategic policy documents,
including the EU Drugs Strategy 2013-2020, the Stockholm
Programme and the Commission Communication â??Towards a stronger
European response to drugsâ??. EU action in the field of new
psychoactive substances is also fully consistent with action at
the United Nations' level.</p>
</tblock>
</tblock>
<tblock currentId="doc_2__tblock_1.6">
<num>1.6.</num>
<heading currentId="doc_2__tblock_1.6__heading">Duration and financial
impact</heading>
<p currentId="doc_2__tblock_1.6__p_1">â?¡ Proposal/initiative of limited duration</p>
<blockList currentId="doc_2__tblock_1.6__lst_1">
<item currentId="doc_2__tblock_1.6__lst_1__item_1">
<num>â??</num>
<p>â?¡ Proposal/initiative in effect from [DD/MM]YYYY to
[DD/MM]YYYY</p>
</item>
<item currentId="doc_2__tblock_1.6__lst_1__item_2">
<num>â??</num>
<p>â?¡ Financial impact from YYYY to YYYY</p>
</item>
</blockList>
<p currentId="doc_2__tblock_1.6__p_2">â? Proposal/initiative of <b currentId="doc_2__tblock_1.6__p_2__b_1">unlimited duration</b></p>
<blockList currentId="doc_2__tblock_1.6__lst_2">
<item currentId="doc_2__tblock_1.6__lst_2__item_1">
<num>â??</num>
<p>Implementation with a start-up period from YYYY to YYYY,</p>
</item>
<item currentId="doc_2__tblock_1.6__lst_2__item_2">
<num>â??</num>
<p>followed by full-scale operation.</p>
</item>
</blockList>
</tblock>
<tblock currentId="doc_2__tblock_1.7">
<num>1.7.</num>
<heading currentId="doc_2__tblock_1.7__heading">Management mode(s)
planned<authorialNote currentId="doc_2__authorialNote_28" marker="28" placement="bottom">
<p>Details of management modes and references to the Financial
Regulation may be found on the BudgWeb site: <a currentId="doc_2__authorialNote_28__p_1__a_1" href="http://www.cc.cec/budg/man/budgmanag/budgmanag_en.html";>http://www.cc.cec/budg/man/budgmanag/budgmanag_en.html</a></p>
</authorialNote></heading>
<p currentId="doc_2__tblock_1.7__p_1"><b currentId="doc_2__tblock_1.7__p_1__b_1"><u currentId="doc_2__tblock_1.7__p_1__b_1__u_1">From the 2014 budget</u></b></p>
<blockList currentId="doc_2__tblock_1.7__lst_1">
<item currentId="doc_2__tblock_1.7__lst_1__item_1">
<p>â? <b currentId="doc_2__tblock_1.7__lst_1__item_1__p_1__b_1">Direct management</b> by the Commission</p>
</item>
<item currentId="doc_2__tblock_1.7__lst_1__item_2">
<num>â??</num>
<p>â? by its departments, including by its staff in the Union
delegations;</p>
</item>
<item currentId="doc_2__tblock_1.7__lst_1__item_3">
<num>â??</num>
<p>â?¡ by the executive agencies;</p>
</item>
</blockList>
<p currentId="doc_2__tblock_1.7__p_2">â?¡ <b currentId="doc_2__tblock_1.7__p_2__b_1"> Shared managemen</b>t with the Member States</p>
<blockList currentId="doc_2__tblock_1.7__lst_2">
<listIntroduction currentId="doc_2__tblock_1.7__lst_2__intro">â?¡
Indirect management by delegating implementation tasks
to:</listIntroduction>
<item currentId="doc_2__tblock_1.7__lst_2__item_1">
<num>â??</num>
<p>â?¡ third countries or the bodies they have designated;</p>
</item>
<item currentId="doc_2__tblock_1.7__lst_2__item_2">
<num>â??</num>
<p>â?¡ international organisations and their agencies (to be
specified);</p>
</item>
<item currentId="doc_2__tblock_1.7__lst_2__item_3">
<num>â??</num>
<p>â?¡the EIB and the European Investment Fund;</p>
</item>
<item currentId="doc_2__tblock_1.7__lst_2__item_4">
<num>â??</num>
<p>â?¡ bodies referred to in Articles 208 and 209 of the Financial
Regulation;</p>
</item>
<item currentId="doc_2__tblock_1.7__lst_2__item_5">
<num>â??</num>
<p>â?¡ public law bodies;</p>
</item>
<item currentId="doc_2__tblock_1.7__lst_2__item_6">
<num>â??</num>
<p>â?¡ bodies governed by private law with a public service
mission to the extent that they provide adequate financial
guarantees;</p>
</item>
<item currentId="doc_2__tblock_1.7__lst_2__item_7">
<num>â??</num>
<p>â?¡ bodies governed by the private law of a Member State that
are entrusted with the implementation of a public-private
partnership and that provide adequate financial
guarantees;</p>
</item>
<item currentId="doc_2__tblock_1.7__lst_2__item_8">
<num>â??</num>
<p>â?¡ persons entrusted with the implementation of specific
actions in the CFSP pursuant to Title V of the TEU, and
identified in the relevant basic act.</p>
</item>
<item currentId="doc_2__tblock_1.7__lst_2__item_9">
<num>â??</num>
<p><span currentId="doc_2__tblock_1.7__lst_2__item_9__p_1__span_1" style="font-size: 10pt;font-style: italic">If more than
one management mode is indicated, please provide details
in the â??Commentsâ?? section.</span></p>
</item>
</blockList>
<p currentId="doc_2__tblock_1.7__p_3">Comments:</p>
<p currentId="doc_2__tblock_1.7__p_4">The only minor costs expected for the EU budget relate to the
evaluation of the legislative instrument and meetings of the
committee of Member States.</p>
</tblock>
</tblock>
<tblock currentId="doc_2__tblock_2">
<num>2.</num>
<heading currentId="doc_2__tblock_2__heading">MANAGEMENT MEASURES</heading>
<tblock currentId="doc_2__tblock_2.1">
<num>2.1.</num>
<heading currentId="doc_2__tblock_2.1__heading">Monitoring and reporting
rules</heading>
<p>The Commission will evaluate the implementation, functioning,
effectiveness, efficiency, utility and added value of the future
mechanism on new psychoactive substances every five years, publish
the results and propose amendments, if necessary.</p>
</tblock>
<tblock currentId="doc_2__tblock_2.2">
<num>2.2.</num>
<heading currentId="doc_2__tblock_2.2__heading">Management and control
system</heading>
<tblock currentId="doc_2__tblock_2.2.1">
<num>2.2.1.</num>
<heading currentId="doc_2__tblock_2.2.1__heading">Risk(s)
identified</heading>
<p>None identified.</p>
</tblock>
<tblock currentId="doc_2__tblock_2.2.2">
<num>2.2.2.</num>
<heading currentId="doc_2__tblock_2.2.2__heading">Information
concerning the internal control system set up</heading>
<p>Standard Commission control/infringement procedures concerning
the application of the future Regulation and Directive.</p>
</tblock>
<tblock currentId="doc_2__tblock_2.2.3">
<num>2.2.3.</num>
<heading currentId="doc_2__tblock_2.2.3__heading">Estimate of the
costs and benefits of the controls and assessment of the
expected level of risk of error</heading>
<p>Not relevant as no specific risk identified.</p>
</tblock>
</tblock>
<tblock currentId="doc_2__tblock_2.3">
<num>2.3.</num>
<heading currentId="doc_2__tblock_2.3__heading">Measures to prevent fraud and
irregularities</heading>
<p>In order to combat fraud, corruption and other unlawful activities,
the provisions of <ref currentId="doc_2__tblock_2.3__p_1__ref_1" href="/eu/act/regulation/1999/1073">Regulation (EC) No
1073/1999</ref> apply.</p>
</tblock>
</tblock>
<tblock currentId="doc_2__tblock_3">
<num>3.</num>
<heading currentId="doc_2__tblock_3__heading">ESTIMATED FINANCIAL IMPACT OF THE
PROPOSAL/INITIATIVE</heading>
<tblock currentId="doc_2__tblock_3.1">
<num>3.1.</num>
<heading currentId="doc_2__tblock_3.1__heading">Heading(s) of the multiannual
financial framework and expenditure budget line(s)
affected</heading>
<blockList currentId="doc_2__tblock_3.1__lst_1">
<item currentId="doc_2__tblock_3.1__lst_1__item_1">
<num>â?¢</num>
<p currentId="doc_2__tblock_3.1__lst_1__item_1__p_1">Existing expenditure budget lines</p>
<p currentId="doc_2__tblock_3.1__lst_1__item_1__p_2"><i currentId="doc_2__tblock_3.1__lst_1__item_1__p_2__i_1">In order</i> of multiannual financial framework headings
and budget lines.</p>
<table currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1">
<tr currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_1">
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_1__td_1" rowspan="2" colspan="1">
<p>Heading of multiannual financial framework</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_1__td_2" colspan="1" rowspan="1">
<p>Budget line</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_1__td_3" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_1__td_3__p_1">Type of</p>
<p currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_1__td_3__p_2">expenditure</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_1__td_4" colspan="4" rowspan="1">
<p>Contribution</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_2">
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_2__td_1" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_2__td_1__p_1">Number</p>
<p currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_2__td_1__p_2"><placeholder currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_2__td_1__p_2__placeholder_1">[�]</placeholder>Heading���������������...���.]</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_2__td_2" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_2__td_2__p_1">Diff./non-diff.</p>
<p currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_2__td_2__p_2">(<authorialNote currentId="doc_2__authorialNote_29" marker="29" placement="bottom">
<p>Diff. = Differentiated appropriations /
Non-Diff. = Non-differentiated appropriations.</p>
</authorialNote>)</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_2__td_3" colspan="1" rowspan="1">
<p>from EFTA countries<authorialNote currentId="doc_2__authorialNote_30" marker="30" placement="bottom">
<p>EFTA: European Free Trade Association.</p>
</authorialNote></p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_2__td_4" colspan="1" rowspan="1">
<p>from candidate countries<authorialNote currentId="doc_2__authorialNote_31" marker="31" placement="bottom">
<p>Candidate countries and, where applicable,
potential candidate countries from the Western
Balkans.</p>
</authorialNote></p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_2__td_5" colspan="1" rowspan="1">
<p>from third countries</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_2__td_6" colspan="1" rowspan="1">
<p>within the meaning of Article 21(2)(b) of the
Financial Regulation</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_3">
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_3__td_1" colspan="1" rowspan="1">
<p>3</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_3__td_2" colspan="1" rowspan="1">
<p>[33 03 03]</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_3__td_3" colspan="1" rowspan="1">
<p>Diff.</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_3__td_4" colspan="1" rowspan="1">
<p>NO</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_3__td_5" colspan="1" rowspan="1">
<p>NO</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_3__td_6" colspan="1" rowspan="1">
<p>NO</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_1__tbl_1__tr_3__td_7" colspan="1" rowspan="1">
<p>NO</p>
</td>
</tr>
</table>
</item>
<item currentId="doc_2__tblock_3.1__lst_1__item_2">
<num>â?¢</num>
<p currentId="doc_2__tblock_3.1__lst_1__item_2__p_1">New budget lines requested</p>
<p currentId="doc_2__tblock_3.1__lst_1__item_2__p_2">In order of multiannual financial framework headings and
budget lines.</p>
<table currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1">
<tr currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_1">
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_1__td_1" rowspan="2" colspan="1">
<p>Heading of multiannual financial framework</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_1__td_2" colspan="1" rowspan="1">
<p>Budget line</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_1__td_3" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_1__td_3__p_1">Type of</p>
<p currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_1__td_3__p_2">expenditure</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_1__td_4" colspan="4" rowspan="1">
<p>Contribution</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_2">
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_2__td_1" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_2__td_1__p_1">Number</p>
<p currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_2__td_1__p_2"><placeholder currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_2__td_1__p_2__placeholder_1">[�]</placeholder>Heading���������������...���.]</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_2__td_2" colspan="1" rowspan="1">
<p>Diff./non-diff.</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_2__td_3" colspan="1" rowspan="1">
<p>from EFTA countries</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_2__td_4" colspan="1" rowspan="1">
<p>from candidate countries</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_2__td_5" colspan="1" rowspan="1">
<p>from third countries</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_2__td_6" colspan="1" rowspan="1">
<p>within the meaning of Article 21(2)(b) of the
Financial Regulation</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_3">
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_3__td_1" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_3__td_2" colspan="1" rowspan="1">
<p><placeholder currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_3__td_2__p_1__placeholder_1">[â?¦]</placeholder>[XX.YY.YY.YY]</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_3__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_3__td_4" colspan="1" rowspan="1">
<p>YES/NO</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_3__td_5" colspan="1" rowspan="1">
<p>YES/NO</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_3__td_6" colspan="1" rowspan="1">
<p>YES/NO</p>
</td>
<td currentId="doc_2__tblock_3.1__lst_1__item_2__tbl_1__tr_3__td_7" colspan="1" rowspan="1">
<p>YES/NO</p>
</td>
</tr>
</table>
</item>
</blockList>
</tblock>
</tblock>
<tblock currentId="doc_2__tblock_3.2">
<num>3.2.</num>
<heading currentId="doc_2__tblock_3.2__heading">Estimated impact on
expenditure</heading>
<tblock currentId="doc_2__tblock_3.2.1">
<num>3.2.1.</num>
<heading currentId="doc_2__tblock_3.2.1__heading">Summary of estimated
impact on expenditure</heading>
<table currentId="doc_2__tblock_3.2.1__tbl_1">
<caption currentId="doc_2__tblock_3.2.1__tbl_1__caption_1">EUR million (to three decimal places)</caption>
<tr currentId="doc_2__tblock_3.2.1__tbl_1__tr_1">
<td currentId="doc_2__tblock_3.2.1__tbl_1__tr_1__td_1" colspan="1" rowspan="1">
<p><b currentId="doc_2__tblock_3.2.1__tbl_1__tr_1__td_1__p_1__b_1">Heading of multiannual
financial<eol currentId="doc_2__tblock_3.2.1__tbl_1__tr_1__td_1__p_1__b_1__eol_1"/>framework</b></p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_1__tr_1__td_2" colspan="1" rowspan="1">
<p>Number</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_1__tr_1__td_3" colspan="1" rowspan="1">
<p>[Heading 3: Security and Citizenship]</p>
</td>
</tr>
</table>
<table currentId="doc_2__tblock_3.2.1__tbl_2">
<tr currentId="doc_2__tblock_3.2.1__tbl_2__tr_1">
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_1" colspan="1" rowspan="1">
<p>DG JUST</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_2" colspan="2" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_4" colspan="1" rowspan="1">
<p>Year<eol currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_4__p_1__eol_2"/>2014</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_5" colspan="1" rowspan="1">
<p>Year<eol currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_5__p_1__eol_3"/>2015</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_6" colspan="1" rowspan="1">
<p>Year<eol currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_6__p_1__eol_4"/>2016</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_7" colspan="1" rowspan="1">
<p>Year<eol currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_7__p_1__eol_5"/>2017</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_8" colspan="1" rowspan="1">
<p>Year<eol currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_8__p_1__eol_6"/>2018</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_9" colspan="1" rowspan="1">
<p>Year<eol currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_9__p_1__eol_7"/>2019</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_10" colspan="1" rowspan="1">
<p>Yean<eol currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_10__p_1__eol_8"/>2020</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_11" colspan="3" rowspan="1">
<p>Enter as many years as necessary to show the duration of
the impact (see paragraph 1.6)</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_1__td_12" colspan="1" rowspan="1">
<p>TOTAL</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_2__tr_2">
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_2__td_1" colspan="4" rowspan="1">
<p>Operational appropriations</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_2__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_2__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_2__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_2__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_2__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_2__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_2__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_2__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_2__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_2__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_2__td_12" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_2__tr_3">
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_3__td_1" rowspan="2" colspan="1">
<p>33 03 03</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_3__td_2" colspan="1" rowspan="1">
<p>Commitments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_3__td_3" colspan="2" rowspan="1">
<p>(1)</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_3__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_3__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_3__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_3__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_3__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_3__td_9" colspan="1" rowspan="1">
<p>0,150</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_3__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_3__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_3__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_3__td_13" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_3__td_14" colspan="1" rowspan="1">
<p>0,150</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_2__tr_4">
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_4__td_1" colspan="1" rowspan="1">
<p>Payments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_4__td_2" colspan="2" rowspan="1">
<p>(2)</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_4__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_4__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_4__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_4__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_4__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_4__td_8" colspan="1" rowspan="1">
<p>0,150</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_4__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_4__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_4__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_4__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_4__td_13" colspan="1" rowspan="1">
<p>0,150</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_2__tr_5">
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_5__td_1" rowspan="2" colspan="1">
<p>Number of budget line</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_5__td_2" colspan="1" rowspan="1">
<p>Commitments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_5__td_3" colspan="2" rowspan="1">
<p>(1a)</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_5__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_5__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_5__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_5__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_5__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_5__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_5__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_5__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_5__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_5__td_13" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_5__td_14" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_2__tr_6">
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_6__td_1" colspan="1" rowspan="1">
<p>Payments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_6__td_2" colspan="1" rowspan="1">
<p>(2a)</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_6__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_6__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_6__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_6__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_6__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_6__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_6__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_6__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_6__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_6__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_6__td_13" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_2__tr_7">
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_7__td_1" colspan="3" rowspan="1">
<p>Appropriations of an administrative nature financed from
the envelope of specific programmes<authorialNote currentId="doc_2__authorialNote_32" marker="32" placement="bottom">
<p>Technical and/or administrative assistance and
expenditure in support of the implementation of EU
programmes and/or actions (former â??BAâ?? lines),
indirect research, direct research.</p>
</authorialNote></p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_7__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_7__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_7__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_7__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_7__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_7__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_7__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_7__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_7__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_7__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_7__td_12" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_2__tr_8">
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_8__td_1" colspan="1" rowspan="1">
<p>Number of budget line</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_8__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_8__td_3" colspan="2" rowspan="1">
<p>(3)</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_8__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_8__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_8__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_8__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_8__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_8__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_8__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_8__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_8__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_8__td_13" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_8__td_14" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_2__tr_9">
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_9__td_1" rowspan="2" colspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_2__tr_9__td_1__p_1">TOTAL appropriations</p>
<p currentId="doc_2__tblock_3.2.1__tbl_2__tr_9__td_1__p_2">for DG JUST</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_9__td_2" colspan="1" rowspan="1">
<p>Commitments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_9__td_3" colspan="2" rowspan="1">
<p>=1+1a +3</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_9__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_9__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_9__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_9__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_9__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_9__td_9" colspan="1" rowspan="1">
<p>0,150</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_9__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_9__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_9__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_9__td_13" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_9__td_14" colspan="1" rowspan="1">
<p>0,150</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_2__tr_10">
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_10__td_1" colspan="1" rowspan="1">
<p>Payments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_10__td_2" colspan="2" rowspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_2__tr_10__td_2__p_1">=2+2a</p>
<p currentId="doc_2__tblock_3.2.1__tbl_2__tr_10__td_2__p_2">+3</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_10__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_10__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_10__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_10__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_10__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_10__td_8" colspan="1" rowspan="1">
<p>0,150</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_10__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_10__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_10__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_10__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_2__tr_10__td_13" colspan="1" rowspan="1">
<p>0,150</p>
</td>
</tr>
</table>
<table currentId="doc_2__tblock_3.2.1__tbl_3">
<tr currentId="doc_2__tblock_3.2.1__tbl_3__tr_1">
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_1__td_1" rowspan="2" colspan="1">
<p>TOTAL operational appropriations</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_1__td_2" colspan="1" rowspan="1">
<p>Commitments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_1__td_3" colspan="1" rowspan="1">
<p>(4)</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_1__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_1__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_1__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_1__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_1__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_1__td_9" colspan="1" rowspan="1">
<p>0,150</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_1__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_1__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_1__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_1__td_13" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_1__td_14" colspan="1" rowspan="1">
<p>0,150</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_3__tr_2">
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_2__td_1" colspan="1" rowspan="1">
<p>Payments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_2__td_2" colspan="1" rowspan="1">
<p>(5)</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_2__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_2__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_2__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_2__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_2__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_2__td_8" colspan="1" rowspan="1">
<p>0,150</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_2__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_2__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_2__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_2__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_2__td_13" colspan="1" rowspan="1">
<p>0,150</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_3__tr_3">
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_3__td_1" colspan="2" rowspan="1">
<p>TOTAL appropriations of an administrative nature financed
from the envelope for specific programmes</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_3__td_2" colspan="1" rowspan="1">
<p>(6)</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_3__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_3__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_3__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_3__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_3__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_3__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_3__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_3__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_3__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_3__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_3__td_13" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_3__tr_4">
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_1" rowspan="2" colspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_1__p_1">TOTAL appropriations</p>
<p currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_1__p_2">for HEADING 3</p>
<p currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_1__p_3">of the multiannual financial framework</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_2" colspan="1" rowspan="1">
<p>Commitments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_3" colspan="1" rowspan="1">
<p>=4+ 6</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_9" colspan="1" rowspan="1">
<p>0,150</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_13" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_4__td_14" colspan="1" rowspan="1">
<p>0,150</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_3__tr_5">
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_5__td_1" colspan="1" rowspan="1">
<p>Payments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_5__td_2" colspan="1" rowspan="1">
<p>=5+ 6</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_5__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_5__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_5__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_5__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_5__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_5__td_8" colspan="1" rowspan="1">
<p>0,150</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_5__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_5__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_5__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_5__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_3__tr_5__td_13" colspan="1" rowspan="1">
<p>0,150</p>
</td>
</tr>
</table>
<p><b currentId="doc_2__tblock_3.2.1__p_1__b_1"><u currentId="doc_2__tblock_3.2.1__p_1__b_1__u_1">If more than one heading is affected by the proposal /
initiative: N/A</u></b></p>
<table currentId="doc_2__tblock_3.2.1__tbl_4">
<tr currentId="doc_2__tblock_3.2.1__tbl_4__tr_1">
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_1__td_1" rowspan="2" colspan="1">
<p>TOTAL operational appropriations</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_1__td_2" colspan="1" rowspan="1">
<p>Commitments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_1__td_3" colspan="1" rowspan="1">
<p>(4)</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_1__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_1__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_1__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_1__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_1__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_1__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_1__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_1__td_11" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_4__tr_2">
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_2__td_1" colspan="1" rowspan="1">
<p>Payments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_2__td_2" colspan="1" rowspan="1">
<p>(5)</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_2__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_2__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_2__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_2__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_2__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_2__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_2__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_2__td_10" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_4__tr_3">
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_3__td_1" colspan="2" rowspan="1">
<p>TOTAL appropriations of an administrative nature financed
from the envelope for specific programmes</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_3__td_2" colspan="1" rowspan="1">
<p>(6)</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_3__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_3__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_3__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_3__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_3__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_3__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_3__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_3__td_10" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_4__tr_4">
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_4__td_1" rowspan="2" colspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_4__tr_4__td_1__p_1">TOTAL appropriations</p>
<p currentId="doc_2__tblock_3.2.1__tbl_4__tr_4__td_1__p_2">under HEADINGS 1 to 4</p>
<p currentId="doc_2__tblock_3.2.1__tbl_4__tr_4__td_1__p_3">of the multiannual financial framework</p>
<p currentId="doc_2__tblock_3.2.1__tbl_4__tr_4__td_1__p_4">(Reference amount)</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_4__td_2" colspan="1" rowspan="1">
<p>Commitments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_4__td_3" colspan="1" rowspan="1">
<p>=4+ 6</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_4__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_4__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_4__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_4__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_4__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_4__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_4__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_4__td_11" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_4__tr_5">
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_5__td_1" colspan="1" rowspan="1">
<p>Payments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_5__td_2" colspan="1" rowspan="1">
<p>=5+ 6</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_5__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_5__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_5__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_5__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_5__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_5__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_5__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_4__tr_5__td_10" colspan="1" rowspan="1"/>
</tr>
</table>
<table currentId="doc_2__tblock_3.2.1__tbl_5">
<tr currentId="doc_2__tblock_3.2.1__tbl_5__tr_1">
<td currentId="doc_2__tblock_3.2.1__tbl_5__tr_1__td_1" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_5__tr_1__td_1__p_1">Heading of multiannual financial</p>
<p currentId="doc_2__tblock_3.2.1__tbl_5__tr_1__td_1__p_2">framework</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_5__tr_1__td_2" colspan="1" rowspan="1">
<p>5</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_5__tr_1__td_3" colspan="1" rowspan="1">
<p>â??Administrative expenditureâ??</p>
</td>
</tr>
</table>
<table currentId="doc_2__tblock_3.2.1__tbl_6">
<caption currentId="doc_2__tblock_3.2.1__tbl_6__caption_1">EUR million (to three decimal places)</caption>
<tr currentId="doc_2__tblock_3.2.1__tbl_6__tr_1">
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_1" colspan="2" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_2" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_2__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_2__p_2">2014</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_3" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_3__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_3__p_2">2015</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_4" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_4__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_4__p_2">2016</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_5" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_5__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_5__p_2">2017</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_6" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_6__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_6__p_2">2018</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_7" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_7__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_7__p_2">2019</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_8" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_8__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_8__p_2">2020</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_1__td_9" colspan="1" rowspan="1">
<p>TOTAL</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_6__tr_2">
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_2__td_1" colspan="2" rowspan="1">
<p>DG JUST</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_6__tr_3">
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_3__td_1" colspan="2" rowspan="1">
<p>Human resources</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_3__td_2" colspan="1" rowspan="1">
<p>0,013</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_3__td_3" colspan="1" rowspan="1">
<p>0,013</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_3__td_4" colspan="1" rowspan="1">
<p>0,013</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_3__td_5" colspan="1" rowspan="1">
<p>0,013</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_3__td_6" colspan="1" rowspan="1">
<p>0,013</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_3__td_7" colspan="1" rowspan="1">
<p>0,065</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_3__td_8" colspan="1" rowspan="1">
<p>0,013</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_3__td_9" colspan="1" rowspan="1">
<p>0,143</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_6__tr_4">
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_4__td_1" colspan="2" rowspan="1">
<p>Other administrative expenditure</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_4__td_2" colspan="1" rowspan="1">
<p>0,025</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_4__td_3" colspan="1" rowspan="1">
<p>0,025</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_4__td_4" colspan="1" rowspan="1">
<p>0,025</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_4__td_5" colspan="1" rowspan="1">
<p>0,025</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_4__td_6" colspan="1" rowspan="1">
<p>0,025</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_4__td_7" colspan="1" rowspan="1">
<p>0,025</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_4__td_8" colspan="1" rowspan="1">
<p>0,025</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_4__td_9" colspan="1" rowspan="1">
<p>0,175</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_6__tr_5">
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_5__td_1" colspan="1" rowspan="1">
<p><b currentId="doc_2__tblock_3.2.1__tbl_6__tr_5__td_1__p_1__b_1">TOTAL DG JUST</b></p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_5__td_2" colspan="2" rowspan="1">
<p>Appropriations</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_5__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_5__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_5__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_5__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_5__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_5__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_5__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_5__td_10" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_6__tr_6">
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_6__td_1" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_6__td_1__p_1">TOTAL appropriations</p>
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_6__td_1__p_2">for HEADINGÂ 5</p>
<p currentId="doc_2__tblock_3.2.1__tbl_6__tr_6__td_1__p_3">of the multiannual financial framework</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_6__td_2" colspan="2" rowspan="1">
<p>Total commitments = Total payments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_6__td_3" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_6__td_4" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_6__td_5" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_6__td_6" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_6__td_7" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_6__td_8" colspan="1" rowspan="1">
<p>0,09</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_6__td_9" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_6__tr_6__td_10" colspan="1" rowspan="1">
<p>0,318</p>
</td>
</tr>
</table>
<table currentId="doc_2__tblock_3.2.1__tbl_7">
<caption currentId="doc_2__tblock_3.2.1__tbl_7__caption_1">EUR million (to three decimal places)</caption>
<tr currentId="doc_2__tblock_3.2.1__tbl_7__tr_1">
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_1" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_4" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_4__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_4__p_2">2014</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_5" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_5__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_5__p_2">2015</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_6" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_6__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_6__p_2">2016</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_7" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_7__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_7__p_2">2017</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_8" colspan="1" rowspan="1">
<p>Year 2018</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_9" colspan="1" rowspan="1">
<p>Year 2019</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_10" colspan="1" rowspan="1">
<p>Year 2020</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_1__td_11" colspan="1" rowspan="1">
<p>TOTAL</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_7__tr_2">
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_2__td_1" rowspan="2" colspan="1">
<p currentId="doc_2__tblock_3.2.1__tbl_7__tr_2__td_1__p_1">TOTAL appropriations</p>
<p currentId="doc_2__tblock_3.2.1__tbl_7__tr_2__td_1__p_2">under HEADINGS 1 to 5</p>
<p currentId="doc_2__tblock_3.2.1__tbl_7__tr_2__td_1__p_3">of the multiannual financial framework</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_2__td_2" colspan="2" rowspan="1">
<p>Commitments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_2__td_3" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_2__td_4" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_2__td_5" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_2__td_6" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_2__td_7" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_2__td_8" colspan="1" rowspan="1">
<p>0,240</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_2__td_9" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_2__td_10" colspan="1" rowspan="1">
<p>0,468</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.1__tbl_7__tr_3">
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_3__td_1" colspan="2" rowspan="1">
<p>Payments</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_3__td_2" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_3__td_3" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_3__td_4" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_3__td_5" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_3__td_6" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_3__td_7" colspan="1" rowspan="1">
<p>0,240</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_3__td_8" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.1__tbl_7__tr_3__td_9" colspan="1" rowspan="1">
<p>0,468</p>
</td>
</tr>
</table>
</tblock>
</tblock>
<tblock currentId="doc_2__tblock_3.2.2">
<num>3.2.2.</num>
<heading currentId="doc_2__tblock_3.2.2__heading">Estimated impact on
operational appropriations</heading>
<p currentId="doc_2__tblock_3.2.2__p_1">â?? ô??? The proposal/initiative does not require the use of
operational appropriations</p>
<p currentId="doc_2__tblock_3.2.2__p_2">â?? x The proposal/initiative requires the use of operational
appropriations, as explained below:</p>
<table currentId="doc_2__tblock_3.2.2__tbl_1">
<caption currentId="doc_2__tblock_3.2.2__tbl_1__caption_1">Commitment appropriations in EUR million (to three decimal
places)</caption>
<tr currentId="doc_2__tblock_3.2.2__tbl_1__tr_1">
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_1" rowspan="3" colspan="1">
<p>Indicate objectives and outputs</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_4" colspan="2" rowspan="1">
<p currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_4__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_4__p_2">2014</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_5" colspan="2" rowspan="1">
<p currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_5__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_5__p_2">2015</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_6" colspan="2" rowspan="1">
<p currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_6__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_6__p_2">2016</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_7" colspan="2" rowspan="1">
<p currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_7__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_7__p_2">2017</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_8" colspan="2" rowspan="1">
<p currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_8__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_8__p_2">2018</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_9" colspan="2" rowspan="1">
<p currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_9__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_9__p_2">2019</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_10" colspan="2" rowspan="1">
<p currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_10__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_10__p_2">2020</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_1__td_11" colspan="2" rowspan="1">
<p>TOTAL</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.2__tbl_1__tr_2">
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_2__td_1" colspan="21" rowspan="1">
<p>OUTPUTS</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.2__tbl_1__tr_3">
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_1" colspan="1" rowspan="1">
<p>Type<authorialNote currentId="doc_2__authorialNote_33" marker="33" placement="bottom">
<p>Outputs are products and services to be supplied
(e.g.: number of student exchanges financed, number
of km of roads built, etc.).</p>
</authorialNote></p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_2" colspan="1" rowspan="1">
<p>Average cost</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_3" colspan="1" rowspan="1">
<p>No</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_4" colspan="1" rowspan="1">
<p>Cost</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_5" colspan="1" rowspan="1">
<p>No</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_6" colspan="1" rowspan="1">
<p>Cost</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_7" colspan="1" rowspan="1">
<p>No</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_8" colspan="1" rowspan="1">
<p>Cost</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_9" colspan="1" rowspan="1">
<p>No</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_10" colspan="1" rowspan="1">
<p>Cost</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_11" colspan="1" rowspan="1">
<p>No</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_12" colspan="1" rowspan="1">
<p>Cost</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_13" colspan="1" rowspan="1">
<p>No</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_14" colspan="1" rowspan="1">
<p>Cost</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_15" colspan="1" rowspan="1">
<p>No</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_16" colspan="1" rowspan="1">
<p>Cost</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_17" colspan="1" rowspan="1">
<p>No total</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_3__td_18" colspan="1" rowspan="1">
<p>Total cost</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.2__tbl_1__tr_4">
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_4__td_1" colspan="3" rowspan="1">
<p>SPECIFIC OBJECTIVE No 1 Prevent and reduce drug use, drug
dependence and drug-related harm</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_4__td_2" colspan="16" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.2__tbl_1__tr_5">
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_1" colspan="1" rowspan="1">
<p>- Output</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_2" colspan="1" rowspan="1">
<p>Evaluation</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_3" colspan="1" rowspan="1">
<p>0,1580</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_13" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_14" colspan="1" rowspan="1">
<p>1</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_15" colspan="1" rowspan="1">
<p>0,150</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_16" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_17" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_18" colspan="1" rowspan="1">
<p>1</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_5__td_19" colspan="1" rowspan="1">
<p>0,150</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.2__tbl_1__tr_6">
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_1" colspan="1" rowspan="1">
<p>- Output</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_13" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_14" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_15" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_16" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_17" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_18" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_6__td_19" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.2__tbl_1__tr_7">
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_1" colspan="1" rowspan="1">
<p>- Output</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_13" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_14" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_15" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_16" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_17" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_18" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_7__td_19" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.2__tbl_1__tr_8">
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_1" colspan="3" rowspan="1">
<p>Subtotal for specific objective No 1</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_12" colspan="1" rowspan="1">
<p>1</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_13" colspan="1" rowspan="1">
<p>0,150</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_14" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_15" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_16" colspan="1" rowspan="1">
<p>1</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_8__td_17" colspan="1" rowspan="1">
<p>0,150</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.2__tbl_1__tr_9">
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_1" colspan="3" rowspan="1">
<p>SPECIFIC OBJECTIVE NO 2 ...</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_13" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_14" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_15" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_16" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_9__td_17" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.2__tbl_1__tr_10">
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_1" colspan="1" rowspan="1">
<p>- Output</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_13" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_14" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_15" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_16" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_17" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_18" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_10__td_19" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.2__tbl_1__tr_11">
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_1" colspan="3" rowspan="1">
<p>Subtotal for specific objective No 2</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_12" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_13" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_14" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_15" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_16" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_11__td_17" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.2__tbl_1__tr_12">
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_1" colspan="3" rowspan="1">
<p>TOTAL COST</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_10" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_11" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_12" colspan="1" rowspan="1">
<p>1</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_13" colspan="1" rowspan="1">
<p>0,150</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_14" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_15" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_16" colspan="1" rowspan="1">
<p>1</p>
</td>
<td currentId="doc_2__tblock_3.2.2__tbl_1__tr_12__td_17" colspan="1" rowspan="1">
<p>0,150</p>
</td>
</tr>
</table>
</tblock>
<tblock currentId="doc_2__tblock_3.2.3">
<num>3.2.3.</num>
<heading currentId="doc_2__tblock_3.2.3__heading">Estimated impact on
appropriations of an administrative nature</heading>
<tblock currentId="doc_2__tblock_3.2.3.1">
<num>3.2.3.1.</num>
<heading currentId="doc_2__tblock_3.2.3.1__heading">Summary</heading>
<table currentId="doc_2__tblock_3.2.3.1__tbl_1">
<caption currentId="doc_2__tblock_3.2.3.1__tbl_1__caption_1">EUR million (to three decimal places)</caption>
<tr currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1">
<td currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_1" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_2" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_2__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_2__p_2">2014</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_3" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_3__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_3__p_2">2015</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_4" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_4__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_4__p_2">2016</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_5" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_5__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_5__p_2">2017</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_6" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_6__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_6__p_2">2018</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_7" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_7__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_7__p_2">2019</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_8" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_8__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_8__p_2">2020</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_1__tr_1__td_9" colspan="1" rowspan="1">
<p>TOTAL</p>
</td>
</tr>
</table>
<table currentId="doc_2__tblock_3.2.3.1__tbl_2">
<tr currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_1">
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_1__td_1" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_1__td_1__p_1">HEADING 5</p>
<p currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_1__td_1__p_2">of the multiannual financial framework</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_1__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_1__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_1__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_1__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_1__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_1__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_1__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_1__td_9" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_2">
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_2__td_1" colspan="1" rowspan="1">
<p>Human resources</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_2__td_2" colspan="1" rowspan="1">
<p>0,013</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_2__td_3" colspan="1" rowspan="1">
<p>0,013</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_2__td_4" colspan="1" rowspan="1">
<p>0,013</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_2__td_5" colspan="1" rowspan="1">
<p>0,013</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_2__td_6" colspan="1" rowspan="1">
<p>0,013</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_2__td_7" colspan="1" rowspan="1">
<p>0,065</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_2__td_8" colspan="1" rowspan="1">
<p>0,013</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_2__td_9" colspan="1" rowspan="1">
<p>0,143</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_3">
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_3__td_1" colspan="1" rowspan="1">
<p>Other administrative expenditure</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_3__td_2" colspan="1" rowspan="1">
<p>0,025</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_3__td_3" colspan="1" rowspan="1">
<p>0,025</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_3__td_4" colspan="1" rowspan="1">
<p>0,025</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_3__td_5" colspan="1" rowspan="1">
<p>0,025</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_3__td_6" colspan="1" rowspan="1">
<p>0,025</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_3__td_7" colspan="1" rowspan="1">
<p>0,025</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_3__td_8" colspan="1" rowspan="1">
<p>0,025</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_3__td_9" colspan="1" rowspan="1">
<p>0,175</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_4">
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_4__td_1" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_4__td_1__p_1">Subtotal HEADING 5</p>
<p currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_4__td_1__p_2">of the multiannual financial framework</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_4__td_2" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_4__td_3" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_4__td_4" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_4__td_5" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_4__td_6" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_4__td_7" colspan="1" rowspan="1">
<p>0,090</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_4__td_8" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_2__tr_4__td_9" colspan="1" rowspan="1">
<p>0,318</p>
</td>
</tr>
</table>
<table currentId="doc_2__tblock_3.2.3.1__tbl_3">
<tr currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_1">
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_1__td_1" colspan="1" rowspan="1">
<p>Outside HEADING 5<authorialNote currentId="doc_2__authorialNote_34" marker="34" placement="bottom">
<p>Technical and/or administrative assistance and
expenditure in support of the implementation of EU
programmes and/or actions (former â??BAâ?? lines),
indirect research, direct research.</p>
</authorialNote> of the multiannual financial
framework</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_1__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_1__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_1__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_1__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_1__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_1__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_1__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_1__td_9" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_2">
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_2__td_1" colspan="1" rowspan="1">
<p>Human resources</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_2__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_2__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_2__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_2__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_2__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_2__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_2__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_2__td_9" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_3">
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_3__td_1" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_3__td_1__p_1">Other expenditure</p>
<p currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_3__td_1__p_2">of an administrative nature</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_3__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_3__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_3__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_3__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_3__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_3__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_3__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_3__td_9" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_4">
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_4__td_1" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_4__td_1__p_1">Subtotal</p>
<p currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_4__td_1__p_2">outside HEADING 5</p>
<p currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_4__td_1__p_3">of the multiannual financial framework</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_4__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_4__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_4__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_4__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_4__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_4__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_4__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.1__tbl_3__tr_4__td_9" colspan="1" rowspan="1"/>
</tr>
</table>
<table currentId="doc_2__tblock_3.2.3.1__tbl_4">
<tr currentId="doc_2__tblock_3.2.3.1__tbl_4__tr_1">
<td currentId="doc_2__tblock_3.2.3.1__tbl_4__tr_1__td_1" colspan="1" rowspan="1">
<p>TOTAL</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_4__tr_1__td_2" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_4__tr_1__td_3" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_4__tr_1__td_4" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_4__tr_1__td_5" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_4__tr_1__td_6" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_4__tr_1__td_7" colspan="1" rowspan="1">
<p>0,090</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_4__tr_1__td_8" colspan="1" rowspan="1">
<p>0,038</p>
</td>
<td currentId="doc_2__tblock_3.2.3.1__tbl_4__tr_1__td_9" colspan="1" rowspan="1">
<p>0,318</p>
</td>
</tr>
</table>
<p>The human resources appropriations required will be met by
appropriations from the DG that are already assigned to management
of the action and/or have been redeployed within the DG, together if
necessary with any additional allocation which may be granted to the
managing DG under the annual allocation procedure and in the light
of budgetary constraints.</p>
</tblock>
</tblock>
<tblock currentId="doc_2__tblock_3.2.3.2">
<num>3.2.3.2.</num>
<heading currentId="doc_2__tblock_3.2.3.2__heading">Estimated
requirements of human resources</heading>
<blockList currentId="doc_2__tblock_3.2.3.2__lst_1">
<listIntroduction currentId="doc_2__tblock_3.2.3.2__lst_1__intro"/>
<item currentId="doc_2__tblock_3.2.3.2__lst_1__item_1">
<num>â??</num>
<p>â?¡ The proposal/initiative does not require the use of human
resources.</p>
</item>
<item currentId="doc_2__tblock_3.2.3.2__lst_1__item_2">
<num>â??</num>
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__p_1">â? The proposal/initiative requires the use of human resources, as
explained below:</p>
<table currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1">
<caption currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__caption_1">Estimate to be expressed in full time equivalent
units</caption>
<tr currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1">
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_1" colspan="2" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_2" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_2__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_2__p_2">2014</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_3" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_3__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_3__p_2">2015</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_4" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_4__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_4__p_2">2016</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_5" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_5__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_5__p_2">2017</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_6" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_6__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_6__p_2">2018</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_7" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_7__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_7__p_2">2019</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_8" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_8__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_8__p_2">2020</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_1__td_9" colspan="1" rowspan="1">
<p>TOTAL</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_2">
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_2__td_1" colspan="10" rowspan="1">
<p>Establishment plan posts (officials and temporary
staff)</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_3">
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_3__td_1" colspan="2" rowspan="1">
<p>33 01 01 01 (Headquarters and Commission's
Representation Offices)</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_3__td_2" colspan="1" rowspan="1">
<p>0,1</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_3__td_3" colspan="1" rowspan="1">
<p>0,1</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_3__td_4" colspan="1" rowspan="1">
<p>0,1</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_3__td_5" colspan="1" rowspan="1">
<p>0,1</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_3__td_6" colspan="1" rowspan="1">
<p>0,1</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_3__td_7" colspan="1" rowspan="1">
<p>0,5</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_3__td_8" colspan="1" rowspan="1">
<p>0,1</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_3__td_9" colspan="1" rowspan="1">
<p>1,1</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_4">
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_4__td_1" colspan="2" rowspan="1">
<p>XX 01 01 02 (Delegations)</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_4__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_4__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_4__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_4__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_4__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_4__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_4__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_4__td_9" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_5">
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_5__td_1" colspan="2" rowspan="1">
<p>XX 01 05 01 (Indirect research)</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_5__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_5__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_5__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_5__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_5__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_5__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_5__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_5__td_9" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_6">
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_6__td_1" colspan="2" rowspan="1">
<p>10 01 05 01 (Direct research)</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_6__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_6__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_6__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_6__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_6__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_6__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_6__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_6__td_9" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_7">
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_7__td_1" colspan="4" rowspan="1">
<p>External staff (in Full Time Equivalent unit:
FTE)<authorialNote currentId="doc_2__authorialNote_35" marker="35" placement="bottom">
<p>CA= Contract Staff; LA = Local Staff; SNE=
Seconded National Expert; INT = agency staff; JED=
Junior Experts in Delegations).</p>
</authorialNote></p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_8">
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_8__td_1" colspan="2" rowspan="1">
<p>XX 01 02 01 (CA, SNE, INT from the â??global
envelopeâ??)</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_8__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_8__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_8__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_8__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_8__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_8__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_8__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_8__td_9" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_9">
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_9__td_1" colspan="2" rowspan="1">
<p>XX 01 02 02 (CA, LA, SNE, INT and JED in the
delegations)</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_9__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_9__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_9__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_9__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_9__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_9__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_9__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_9__td_9" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_10">
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_10__td_1" rowspan="2" colspan="1">
<p>XX 01 04 yy<authorialNote currentId="doc_2__authorialNote_36" marker="36" placement="bottom">
<p>Sub-ceiling for external staff covered by
operational appropriations (former â??BAâ??
lines).</p>
</authorialNote></p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_10__td_2" colspan="1" rowspan="1">
<p>- at Headquarters</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_10__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_10__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_10__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_10__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_10__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_10__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_10__td_9" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_10__td_10" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_11">
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_11__td_1" colspan="1" rowspan="1">
<p>- Delegations</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_11__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_11__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_11__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_11__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_11__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_11__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_11__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_11__td_9" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_12">
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_12__td_1" colspan="2" rowspan="1">
<p>XX 01 05 02 (CA, SNE, INT - Indirect research)</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_12__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_12__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_12__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_12__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_12__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_12__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_12__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_12__td_9" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_13">
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_13__td_1" colspan="2" rowspan="1">
<p>10 01 05 02 (CA, INT, SNE - Direct research)</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_13__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_13__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_13__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_13__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_13__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_13__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_13__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_13__td_9" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_14">
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_14__td_1" colspan="2" rowspan="1">
<p>Other budget lines (specify)</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_14__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_14__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_14__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_14__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_14__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_14__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_14__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_14__td_9" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_15">
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_15__td_1" colspan="2" rowspan="1">
<p>TOTAL</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_15__td_2" colspan="1" rowspan="1">
<p>0,1</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_15__td_3" colspan="1" rowspan="1">
<p>0,1</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_15__td_4" colspan="1" rowspan="1">
<p>0,1</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_15__td_5" colspan="1" rowspan="1">
<p>0,1</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_15__td_6" colspan="1" rowspan="1">
<p>0,1</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_15__td_7" colspan="1" rowspan="1">
<p>0,5</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_15__td_8" colspan="1" rowspan="1">
<p>0,1</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__tbl_1__tr_15__td_9" colspan="1" rowspan="1">
<p>1,1</p>
</td>
</tr>
</table>
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__p_2">33 is the policy area or budget title concerned.</p>
<p currentId="doc_2__tblock_3.2.3.2__lst_1__item_2__p_3">The human resources required will be met by staff from the DG who
are already assigned to management of the action and/or have
been redeployed within the DG, together if necessary with any
additional allocation which may be granted to the managing DG
under the annual allocation procedure and in the light of
budgetary constraints.</p>
</item>
</blockList>
<p>Description of tasks to be carried out:</p>
<table currentId="doc_2__tblock_3.2.3.2__tbl_1">
<tr currentId="doc_2__tblock_3.2.3.2__tbl_1__tr_1">
<td currentId="doc_2__tblock_3.2.3.2__tbl_1__tr_1__td_1" colspan="1" rowspan="1">
<p>Officials and temporary staff</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__tbl_1__tr_1__td_2" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.3.2__tbl_1__tr_1__td_2__p_1">Preparation of one committee meeting of Member States per
year.</p>
<p currentId="doc_2__tblock_3.2.3.2__tbl_1__tr_1__td_2__p_2">Coordination of an external study for the evaluation of the
instrument every five years.</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.2.3.2__tbl_1__tr_2">
<td currentId="doc_2__tblock_3.2.3.2__tbl_1__tr_2__td_1" colspan="1" rowspan="1">
<p>External staff</p>
</td>
<td currentId="doc_2__tblock_3.2.3.2__tbl_1__tr_2__td_2" colspan="1" rowspan="1"/>
</tr>
</table>
</tblock>
<tblock currentId="doc_2__tblock_3.2.4">
<num>3.2.4.</num>
<heading currentId="doc_2__tblock_3.2.4__heading">Compatibility with the
current multiannual financial framework</heading>
<blockList currentId="doc_2__tblock_3.2.4__lst_1">
<item currentId="doc_2__tblock_3.2.4__lst_1__item_1">
<num>â??</num>
<p>â? Proposal/initiative is compatible with the current multiannual
financial framework.</p>
</item>
<item currentId="doc_2__tblock_3.2.4__lst_1__item_2">
<num>â??</num>
<p>â?¡ Proposal/initiative will entail reprogramming of the relevant
heading in the multiannual financial framework.</p>
<table currentId="doc_2__tblock_3.2.4__lst_1__item_2__tbl_1">
<tr currentId="doc_2__tblock_3.2.4__lst_1__item_2__tbl_1__tr_1">
<td currentId="doc_2__tblock_3.2.4__lst_1__item_2__tbl_1__tr_1__td_1" colspan="1" rowspan="1">
<p>Explain what reprogramming is required, specifying
the budget lines concerned and the corresponding
amounts.</p>
</td>
</tr>
</table>
</item>
<item currentId="doc_2__tblock_3.2.4__lst_1__item_3">
<num>â??</num>
<p>â?¡ Proposal/initiative requires application of the flexibility
instrument or revision of the multiannual financial
framework.</p>
<table currentId="doc_2__tblock_3.2.4__lst_1__item_3__tbl_1">
<tr currentId="doc_2__tblock_3.2.4__lst_1__item_3__tbl_1__tr_1">
<td currentId="doc_2__tblock_3.2.4__lst_1__item_3__tbl_1__tr_1__td_1" colspan="1" rowspan="1">
<p>Explain what is required, specifying the headings and
budget lines concerned and the corresponding
amounts.</p>
</td>
</tr>
</table>
</item>
</blockList>
</tblock>
<tblock currentId="doc_2__tblock_3.2.5">
<num>3.2.5.</num>
<heading currentId="doc_2__tblock_3.2.5__heading">Third-party
contributions</heading>
<blockList currentId="doc_2__tblock_3.2.5__lst_1">
<item currentId="doc_2__tblock_3.2.5__lst_1__item_1">
<num>â??</num>
<p>The proposal/initiative does not provide for co-financing by
third parties.</p>
</item>
<item currentId="doc_2__tblock_3.2.5__lst_1__item_2">
<num>â??</num>
<p>The proposal/initiative provides for the co-financing estimated
below:</p>
<table currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1">
<caption currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__caption_1">Appropriations in EUR million (to 3 decimal
places)</caption>
<tr currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_1">
<th currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_1__th_1" colspan="1" rowspan="1"/>
<th currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_1__th_2" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_1__th_2__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_1__th_2__p_2">N</p>
</th>
<th currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_1__th_3" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_1__th_3__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_1__th_3__p_2">N+1</p>
</th>
<th currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_1__th_4" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_1__th_4__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_1__th_4__p_2">N+2</p>
</th>
<th currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_1__th_5" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_1__th_5__p_1">Year</p>
<p currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_1__th_5__p_2">N+3</p>
</th>
<th currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_1__th_6" colspan="3" rowspan="1">
<p>Enter as many years as necessary to show the duration
of the impact (see paragraph 1.6)</p>
</th>
<th currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_1__th_7" colspan="1" rowspan="1">
<p>Total</p>
</th>
</tr>
<tr currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_2">
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_2__td_1" colspan="1" rowspan="1">
<p>Specify the co-financing body</p>
</td>
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_2__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_2__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_2__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_2__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_2__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_2__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_2__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_2__td_9" colspan="1" rowspan="1"/>
</tr>
<tr currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_3">
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_3__td_1" colspan="1" rowspan="1">
<p>TOTAL appropriations cofinanced</p>
</td>
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_3__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_3__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_3__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_3__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_3__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_3__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_3__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.2.5__lst_1__item_2__tbl_1__tr_3__td_9" colspan="1" rowspan="1"/>
</tr>
</table>
</item>
</blockList>
</tblock>
<tblock currentId="doc_2__tblock_3.3">
<num>3.3.</num>
<heading currentId="doc_2__tblock_3.3__heading">Estimated impact on
revenue</heading>
<blockList currentId="doc_2__tblock_3.3__lst_1">
<item currentId="doc_2__tblock_3.3__lst_1__item_1">
<num>â??</num>
<p>â? Proposal/initiative has no financial impact on revenue.</p>
</item>
<item currentId="doc_2__tblock_3.3__lst_1__item_2">
<num>â??</num>
<p currentId="doc_2__tblock_3.3__lst_1__item_2__p_1">â?¡ Proposal/initiative has the following financial impact:</p>
<blockList currentId="doc_2__tblock_3.3__lst_1__item_2__lst_1">
<item currentId="doc_2__tblock_3.3__lst_1__item_2__lst_1__item_1">
<num>â??</num>
<p>â?¡ on own resources</p>
</item>
<item currentId="doc_2__tblock_3.3__lst_1__item_2__lst_1__item_2">
<num>â??</num>
<p>â?¡ on miscellaneous revenue</p>
</item>
</blockList>
<table currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1">
<caption currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__caption_1">EUR million (to three decimal places)</caption>
<tr currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_1">
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_1__td_1" rowspan="2" colspan="1">
<p>Budget revenue line:</p>
</td>
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_1__td_2" rowspan="2" colspan="1">
<p>Appropriations available for the current financial
year</p>
</td>
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_1__td_3" colspan="7" rowspan="1">
<p>Impact of the proposal/initiative<authorialNote currentId="doc_2__authorialNote_38" marker="38" placement="bottom">
<p>As regards traditional own resources (customs
duties, sugar levies), the amounts indicated must
be net amounts, i.e. gross amounts after deduction
of 25% for collection costs.</p>
</authorialNote></p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_2">
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_2__td_1" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_2__td_1__p_1">Year</p>
<p currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_2__td_1__p_2">N</p>
</td>
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_2__td_2" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_2__td_2__p_1">Year</p>
<p currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_2__td_2__p_2">N+1</p>
</td>
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_2__td_3" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_2__td_3__p_1">Year</p>
<p currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_2__td_3__p_2">N+2</p>
</td>
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_2__td_4" colspan="1" rowspan="1">
<p currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_2__td_4__p_1">Year</p>
<p currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_2__td_4__p_2">N+3</p>
</td>
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_2__td_5" colspan="3" rowspan="1">
<p>Enter as many years as necessary to show the duration
of the impact (see paragraph 1.6)</p>
</td>
</tr>
<tr currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_3">
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_3__td_1" colspan="1" rowspan="1">
<p>Article ����.</p>
</td>
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_3__td_2" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_3__td_3" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_3__td_4" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_3__td_5" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_3__td_6" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_3__td_7" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_3__td_8" colspan="1" rowspan="1"/>
<td currentId="doc_2__tblock_3.3__lst_1__item_2__tbl_1__tr_3__td_9" colspan="1" rowspan="1"/>
</tr>
</table>
<p currentId="doc_2__tblock_3.3__lst_1__item_2__p_2">For miscellaneous â??assignedâ?? revenue, specify the budget
expenditure line(s) affected.</p>
<p currentId="doc_2__tblock_3.3__lst_1__item_2__p_3">Specify the method for calculating the impact on revenue.</p>
</item>
</blockList>
</tblock>
</mainBody>
</doc>
</component>
</components>
</akomaNtoso>Attachment:
currentId- building-rules-v1.odt
Description: Binary data
[Date Prev] | [Thread Prev] | [Thread Next] | [Date Next] -- [Date Index] | [Thread Index] | [List Home]